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Assertive	community		 2010	Cochrane	review	of	intensive		 Effective	at	reducing		 Moderate		 8	studies	(China	[88,	89],	Iran		 May	be	effective	at	reducing		
treatment		 case	management		(38	studies-	0		 hospitalisation,		 quality		 [90,	91],	Malaysia	[92],	South		 admissions	&	relapse	rates,			 LMIC)	[87]		 increasing	social		 	 Africa	[93-95],	Turkey	[96])		 and	improving	functioning.				 	 functioning,	increasing		 	 	 		 	 retention	in	care		 	 	 	
		 2015	Cochrane	review	of	crisis	intervention	(8	studies-	0	LMIC	[97]		 Effective	at	reducing	hospital	admissions			 Low	–	moderate	quality		
None	identified		 n/a		
Supported	employment		 2013	Cochrane	review	of	supported	employment	(14	studies	–	0	LMIC)	[98]		










































2014	systematic	review	of	peer	support	(18	studies-	0	LMIC)	[144]		 No	evidence	of	effectiveness		 Low	quality		 None	identified			 n/a		






















• Projects	aiming	 to	 formalise	 collaborations	between	health	care	providers	and	traditional	or	religious	healers	in	sub-Saharan	Africa	[177-179].	
• Initiatives	 using	 mobile	 and	 information	 technologies	 to	 facilitate	 mental	healthcare	delivery	and	collaboration	[178-181].	
• Mobile	clinics	of	mental	health	specialists	visiting	remote	areas	[182].	
• Peer	 support	 groups	 in	Ghana	 [183]	 and	peer	 support	workers	delivering	home-based	care	in	Chile	and	Uganda	[184-186].	
• Initiatives	focused	on	removing	physical	restraints	from	people	with	mental	illness	at	home	or	hospital	(see	Section	2.10.2),	for	example	the	Chain	Free	Initiative	 in	 Somalia	 [187],	 targeted	 programmes	 in	 Indonesia	 [188],	 and	the	 ‘unlocking	and	treatment’	 intervention	part	of	 the	 ‘686’	programme	in	China	[189].	






















2. CBR	 targets	 the	 key	 environmental	 factors	 (access	 to	 health	 services,	stigma)	and	personal	factors	(poverty,	coping	styles,	health	literacy)	which	create	 these	 high	 levels	 of	 disability	 (see	 Section	 2.3.1),	 in	 particular	through	utilising	a	development	approach	and	operating	within	an	explicit	human	rights	framework.		
3. Family	 members	 are	 heavily	 implicated	 in	 the	 lives	 of	 people	 with	schizophrenia	in	these	settings,	both	in	terms	of	experiencing	the	negative	impacts	such	as	stigma	and	economic	insecurity,	but	also	through	taking	on	a	 prominent	 caregiving	 role	 (see	 Section	 2.9.4).	 CBR	 explicitly	 engages	family	members.		
4. CBR	 aligns	 with	 the	 personal	 recovery	 model,	 as	 there	 is	 a	 focus	 on	empowerment	and	participation	(see	Section	2.4).			
5. CBR	 is	 a	means	of	providing	on-going	 community-based	 care	yet	 requires	low	 levels	of	 technical	expertise	so	may	be	 implemented	by	non-specialist	workers	 (see	 Section	 2.6.2).	 This	 is	 of	 utmost	 value	 in	 settings	 with	 few	formal	health	resources	such	as	Ethiopia	(see	Section	2.9.2).		
48










































2.10.1 Stigma	and	discrimination	It	has	been	shown	that	stigma	towards	people	with	mental	illness	is	a	universal	phenomenon,	transcending	economic	and	cultural	boundaries	[246,	247].	The	issue	of	stigma	includes	problems	of	knowledge	(misinformation),	attitudes	(prejudice)	and	behaviour	(discrimination)	[247].	Perceived	and	internalized	stigma	refer	to	the	experiences	of	people	with	mental	illness,	whereas	public	stigma	concerns	the	negative	attitudes	of	the	general	population	[248].	A	“backbone”	of	public	stigma	across	continents	seems	to	comprise	difficulty	accepting	that	people	with	mental	illness	can	take	authority	positions	and	discomfort	at	interactions	with	this	group,	underpinned	by	fear	of	possible	violence	[246].	However,	differences	in	the	extent	and	nature	of	stigma	have	been	identified	between	settings,	hence	the	phenomenon	is	also	understood	as	a	local	experience	[249].	In	all	settings,	a	low	level	of	mental	health	literacy	is	thought	to	be	one	of	the	factors	contributing	to	negative	attitudes	[219,	250].		 In	Ethiopia,	high	levels	of	internalised	stigma	have	been	found	in	people	with	schizophrenia.	In	one	survey	of	psychiatric	inpatients	nearly	all	participants	(97.4%)	reported	at	least	one	experience	of	internalised	stigma	and	46.7%	had	a	moderate	to	high	mean	stigma	score	[251].	In	Ethiopia	caregivers	of	people	with	mental	illness	are	also	stigmatised	[22,	252],	which	may	manifest	as	greater	burden	due	an	absence	of	community	support.	High	levels	of	public	stigma	have	been	demonstrated	in	Ethiopia	[219],	with	attitudes	generally	less	favourable	towards	people	with	psychotic	illness	compared	to	other	mental	disorders	[215].	Community-based	surveys	have	shown	greater	levels	of	public	stigma	in	rural	areas	and	amongst	those	with	lower	education	levels	[215,	219].		 Stigma	may	have	important	implications	for	the	experiences	of	people	with	mental	illness,	increasing	the	risk	of	self	harm	[253]	as	well	as	potentially	affecting	access	to	health	services,	and	adherence	to	treatment	[251].	Discrimination	may	lead	to	social	exclusion	of	people	with	schizophrenia	and	may	act	as	a	barrier	to	recovery	[247].	The	high	levels	of	violent	victimisation	identified	amongst	participants	in	the	Butajira	cohort	may	be	partly	attributable	to	stigma	[24].	
59
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Hegde		 Individual			 Schizophrenia			 2	months.	(i)	Cognitive	retraining:		 Researcher			 None		 Drug	treatment	and		 Symptoms:	Positive	association	with		
2012	[22]		 		 n=	45			 home	visits	for	cognitive	retraining		 	 	 psychoeducation		 negative	symptoms.			
		 6	months		 [I=22,	C=23]		 tasks	and	(ii)	Psychoeducation:	3		 	 	 	 Cognition:	Positive	association		
India		 	 	 sessions	45-60min.	Medication.		 	 	 	 	
Li	2005		 Cluster		 Schizophrenia			 3	months.	Family	and	patient		 Trained	nurse			 None		 Medication/	standard		 Symptoms:	Positive	association	at	9		
[17]		 		 n=101			 psycho-education	in	hospital	(8h		 	 	 inpatient	care		 months;	no	association	at	3	months.		
		 9	months		 [I=46,	C=55]		 with	pt,	36	hrs	with	family)	and	then		 	 	 	 Functioning:	Positive	association	at		
China		 	 	 at	home	(2	hrs/month	for	3	months		 	 	 	 9	months;	no	association	at	3	months.			 	 	 post-discharge).	Phases:	establish		 	 	 	 Medication	adherence:	No			 	 	 trust,	assess	needs;	psychoeducation,		 	 	 	 association.			 	 	 develop	coping	skills.	Medication.		 	 	 	 Knowledge:	Positive	association			
Xiang		 Individual		 Schizophrenia		 4	months.	Family	psychoeducation		 Not	stated		 Health		 Monthly	drug		 Symptoms:	Positive	association		
1994	[18]		 multisite		 and	affective		 (family	visits,	workshop,	monthly		 	 education		 treatment			 Functioning:	Positive	association		
		 		 psychoses		 supervision).	Medication.		 	 through		 	 with	work	ability	and	poor	social		
China		 4	months			 n=77			 	 	 village	wired		 	 functioning.				 	 [I=36,	C=41]		 	 	 radio	network		 	 Medication	adherence:	Positive			 	 	 	 	 	 	 association		
Zhang		 Individual		 Schizophrenia		 18	months.	Family		 Counsellors			 None		 Outpatient	care	-		 Symptoms:	Positive	association			
1994	[19]		 		 n=83			 psychoeducation:	initial	home	visit,		 	 	 including	medication;		 Functioning:	Positive	association		
		 18	months		 [I=39,	C=39]		 then	3	monthly	group	sessions	or		 	 	 no	active	follow	up	for		 Readmission:	Positive	association		























Cai	2015		 Individual		 Schizophrenia			 10	weeks.	Comprehensive	family		 Professional		 None		 Usual	care	(usually		 Symptoms:	No	association		
[20]		 multisite		 n=	256	[I=133,		 therapy:	(i)	Social	skills	training		 personnel		 	 monthly	outpatient		 Cognition:	Positive	association		(greater		
		 		 C=123]		 (medication	and	symptom		 	 	 appointment)		 improvements	since	baseline	compared		
China		 18	months			 	 management,	community	re-entry		 	 	 	 to	control	(p=0.002))			 	 	 support,	recreation	for	leisure	and		 	 	 	 		 	 	 social	independent	living	skills)	90–	 	 	 	 		 	 	 120	minutes/session,	2	sessions/		 	 	 	 		 	 	 week	for	10	weeks	(ii)	Family		 	 	 	 		 	 	 psychoeducation.	One	session/		 	 	 	 		 	 	 week	for	10	weeks.	Medication.		 	 	 	 	
Chatterjee		 Individual			 Schizophrenia			 12	months.	Collaborative		 Lay		 Referrals	to		 Facility	based	care.		 Symptoms:	Non-significant	association		
2014	[21]		 multisite		 n	=282	[I=187,		 community	based	care:	Home	visits		 community		 community		 Psychiatrist		 (p=0.08).			
		 		 C=95]		 fortnightly	for	7	months,	then		 health		 agencies:		 consultations.	Anti-	 Functioning:	Positive	association.		
India		 12	months		 	 monthly	for	5	months.	Psycho-	 workers		 address	social		 psychotic		 Significant	differences	in	PANSS	and			 	 	 education;	address	stigma	and		 	 inclusion,		 medication,		 IDEAS	at	rural	site,	but	not	at	others.			 	 	 discrimination;	adherence		 	 access	to	legal		 information	about		 Medication	adherence:	Positive			 	 	 management	strategies;	health		 	 benefits,		 illness,	encouraged		 association				 	 	 promotion;	rehabilitation	strategies		 	 employment		 medication		 Stigma,	knowledge	about			 	 	 to	improve	social/vocational		 	 	 adherence.			 schizophrenia,	caregiver	burden:	No			 	 	 functioning.	Medication.		 	 	 	 association.			
Ran	2015		 Cluster			 Schizophrenia			 9	months.	Psycho-educational		 Psychiatrists		 Local	village		 1.Medication	alone		 Symptoms:	Borderline	association	9		
[16]	[15]		 		 n=	326	[I=126,		 family	intervention	(i)	Family		 and	village		 broadcast		 2.	Control	(no		 months,	no	association	36	months.		
		 9	months		 C1=103,	2=97]		 education	1x/month:	information		 doctors		 network	used		 intervention,		 Functioning:	No	association	compared		

























Botha	 Individual	 Schizophrenia	or	 12	months.	Assertive	community	 Key	worker	 Strengthening	 Community	mental	health	 12	months	Symptoms:	Positive	
2014	[25,	 	 schizoaffective	 treatment:	individual	caseload	max	 (social	worker	 access	to	 team:	caseload	250+,	 association	
26]	 12	 disorder	 35.	Visits	>50%	at	home,	fortnightly	or	 or	nurse),	 existing	 outpatient	appts	1-3	 Functioning:	Positive	association		 months	 n=	60	 according	to	need.	Focused	on	 supported	by	 community	 monthly;	no	active	follow	 Inpatient	days+readmissions:	
South	 and	36	 [I=34,	C=26]	 engagement	and	maintaining	 multi-	 resources	 up;	referral	to	allied	health	 Positive	association	
Africa	 months	 	 adherence;	referral	to	psychologist,	 disciplinary	 	 professionals.	Medication.	 Quality	of	life	and	depression:		 	 	 occupational	therapist;	access	to	 team	 	 	 No	association		 	 	 psychosocial	rehab	program.	 (psychiatrist,	 	 	 36	months	Inpatient	days	and		 	 	 Medication.	 psych	nurse)	 	 	 readmissions:	Positive		 	 	 	 	 	 	 association	
Sharifi	 Individual	 Schizophrenia,	 12	months.	Home	after	care	Monthly	 General	 Help	family	to	 Hospital	outpatient	service	 Symptoms:	Positive	association	
2012	[24]	 	 schizoaffective	 visits	with	extra	visits	in	first	3	 practitioner	 access	 (no	psychosocial	 Functioning:	No	association		 12	 disorder,	bipolar	 months.	Care	plan,	drug	prescription,	 and	social	 supportive	and	 component)	 Readmissions:	Positive	
Iran	 months	 n=130	 dose	adjustment,	psychoeducation,	 worker-	plan	 community	 	 association		 	 [I=66,	C=64]	 relapse	recognition,	referral	to	 reviewed	by	 resources.	 	 Quality	of	life:	No	association		 	 	 hospital.	Medication.	 psychiatrist	 	 	 Depression:	Positive	association	
Ghadiri	 Individual	 Schizophrenia,	 20	months.	Home	aftercare	(i)	 Not	stated	 Contact	with	 Usual	aftercare	including	 Symptoms:	Positive	association	
2015	[23]	 	 schizoaffective	 Treatment	follow	up	(home	 	 local	NGOs	and	 monthly	visits	by	 Inpatient	days	and		 20	 and	bipolar	 visits/telephone	and	monthly	 	 self	help	groups	 psychiatrist	 readmissions:	Positive	
Iran	 months	 disorder	 outpatient	visit)	(ii)	Family	 	 	 	 association		 	 n=120	 psychoeducation	(six	weekly	2-hr	 	 	 	 Depression:	Positive	association		 	 [I=60,	C=60]	 sessions),	(iii)	social	skills	training	(9	 	 	 	 		 	 	 monthly	visits).	Medication.	 	 	 	 	
Sungur	 Individual	 Schizophrenia	 24	months.	Optimal	case	 Psychiatrists,	 Referrals	to	 Routine	case	management	 Symptoms:	Positive	association	
2011	[27]	 	 n=100	 management:	psychoeducation,	 psychologist,	 voluntary	 (outpatient	clinic):	 Functioning:	Positive	association		 24	 [I=50,	C=50]	 adherence	strategies,	relapse	 psychiatric	 organisations	 psychoeducation,	 Quality	of	life:	Positive	





































































































































Botha	2014	 	 	 	 	 	 	 	 	 	 	 	 Low/	unclear	
Cai	2015	 	 	 	 	 	 	 		 	 	 	 	 	 Low/	unclear	
Chatterjee	
2014	 	 	 	 	 	 	 	 	 	 	 	 	 Low	
Ghadiri	2015	 	 	 	 	 	 	 	 	 	 	 	 	 High	
Hegde	2012	 	 	 	 	 	 	 	 	 	 	 	 	 High	
Li	2005	 	 	 	 	 	 	 	 	 	 	 	 	 High	
Ran	2015	 	 	 	 	 	 	 	 	 	 	 	 Low/	unclear	
Sharifi	2012	 	 	 	 	 	 	 	 	 		 	 	 	 High	
Sungur	2011	 	 	 	 	 	 	 	 	 	 	 	 	 Low/	unclear	
Xiang	1994	 	 	 	 	 	 	 	 	 	 	 	 	 Low/	unclear	
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Community-based rehabilitation (CBR) is a multi-sectoral strategy to improve the function- 
ing and quality of life of people with disabilities. The RISE (Rehabilitation Intervention for 
people with Schizophrenia in Ethiopia) trial will evaluate the effectiveness of CBR for people 
with schizophrenia in Ethiopia. Nevertheless, the components of CBR that are both feasible 




In this study intervention development work was undertaken to design a CBR intervention 
that is acceptable and feasible in the local context. The development work consisted of five 
phases. 1: Identify potential components of CBR for schizophrenia, 2: Situational analysis, 
3: Determine feasibility of CBR (Theory of Change workshops with experts and local stake- 
holders), 4: Determine acceptability of CBR (16 in-depth interviews and five focus group dis- 
cussions with people with schizophrenia, caregivers, health workers and community 
leaders) and 5: Synthesise results to finalise intervention. A Theory of Change map was 
constructed showing the causal pathway for how we expect CBR to achieve its impact. 
 
Results 
People with schizophrenia in rural Ethiopia experience family conflict, difficulty participating 
in work and community life, and stigma. Stakeholders perceived CBR to be acceptable and 
useful to address these problems. The focus of CBR will be on the individual developing the 
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feasibility, non-health professionals will be trained to deliver CBR and provide supervision, 
rather than mental health specialists. Novel components of CBR for schizophrenia included 
family intervention and dealing with distressing symptoms. Microfinance was excluded due 
to concerns about stress and exploitation. Community mobilisation was viewed as essential 
to ensure the effectiveness and sustainability of CBR. 
 
Conclusion 
Extensive formative research using a variety of methods has enabled the design of a cultur- 







Many people with schizophrenia experience severe and chronic illness; in Ethiopia 38% had 
episodic symptoms and 19% had continuous symptoms over a 10-year period whilst 11.8% 
had complete remission after one episode [1]. Reflecting global patterns, in Ethiopia, people 
with schizophrenia have high levels of disability [2], family burden [3], stigma [4, 5], and mor- 
tality [6]. Despite this, the majority of people with schizophrenia in low and middle income 
countries (LMIC) do not have access to adequate care; in Ethiopia, the treatment gap is 90% 
[7]. Human rights violations also occur [8] and many are the victims of violence [9]. Treatment 
with antipsychotic medication alone is often not adequate to achieve functional recovery and 
social reintegration [11]. Psychosocial or psychiatric rehabilitation is recognised globally as an 
essential component of care for people with schizophrenia. Psychosocial rehabilitation is “a 
process that facilitates the opportunity for individuals.. .to reach their optimum level of inde- 
pendent functioning in the community”[ 12]. There is also increasing agreement that the man- 
agement of schizophrenia should be guided by the principle of recovery, in which the focus is 
on empowerment, self-direction, personal responsibility and hope [13, 14]. The WHO’s mental 
health Gap Action Programme (mhGAP) recommends that schizophrenia management 
should include psychosocial interventions, including community-based rehabilitation (CBR), 
where available, although evidence from LMIC settings is limited [ 15, 16]. CBR is a strategy 
that aims to reduce disability and improve the quality of life and social inclusion of people with 
disabilities. CBR echoes the ethos of psychosocial rehabilitation, particularly drawing on recov- 
ery values, whilst reflecting the particular needs of low-income settings [17]. 
Programmes cover one or more of the CBR pillars (health, education, livelihoods, social and 
empowerment), focused on facilitating individuals to access existing resources [17]. CBR is put 
into practice through the joint endeavours of people with disabilities, their caregivers, commu- 
nity members and public sector services e.g. health services [18]. There is a long-standing tradi- 
tion of CBR and a global network of CBR programmes, but these have historically focused on 
other disabilities. There is now increasing recognition that people with mental illnesses may 
receive substantial benefit from CBR. As such mental health has been incorporated into CBR 
programmes in Sri Lanka, India, West Africa, China and Latin America [17, 19–21]. A system- 
atic review found that aspects of CBR may improve clinical outcomes and functioning for 
schizophrenia, dementia and intellectual disabilities in LMICs [ 18]. There is evidence from 
randomised controlled trials (RCTs) to support the effectiveness of assertive community treat- 
ment (ACT) for people with schizophrenia in South Africa [22] and psycho-educational family 
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schizophrenia that involved community mobilisation (defined as “a strategy which aims to 
engage community members and empower them for change or action”[17]) or that focused 
primarily on any pillar other than health, were included [18]. The more recent COmmunity 
care for People with Schizophrenia in India (COPSI) trial [25] found collaborative community 
care modestly improved disability and symptoms in people with schizophrenia [ 26]. Whilst 
influenced by CBR, the intervention did not include community mobilisation. 
In summary, CBR is a promising intervention for people with chronic and disabling schizo- 
phrenia (due to illness factors or structural factors which lead to drop out from care) particu- 
larly in low-income settings where treatment options for this group are limited. Yet there has 
been no systematic adaptation of comprehensive CBR for people with schizophrenia nor 
assessment of its effectiveness in low and middle-income countries. The Rehabilitation Inter- 
vention for people with Schizophrenia in Ethiopia (RISE) project aims to adapt CBR for people 
with schizophrenia in a rural Ethiopian setting and to assess its effectiveness. The RISE trial 
(NCT02160249) will determine whether CBR as an adjunct to facility-based care is superior to 
facility-based care alone in reducing disability in people with schizophrenia who remain symp- 
tomatic or disabled after six months of treatment. This will be the first comprehensive CBR 
programme for mental illness to be evaluated in a clinical trial in Africa. The intensive CBR 
intervention will be targeted at those with the greatest need. The rationale for this is (i) the aim 
of CBR is to reduce disability, so it is appropriate primarily for those who are disabled and (ii) 
to increase feasibility for scale-up by restricting the intervention to those most in need. RISE is 
nested in PRIME (Programme for Improving Mental healthcarE), a five-country research con- 
sortium, including Ethiopia, which aims to generate evidence on the integration of mental 
health into primary care in LMIC [27, 28]. As part of PRIME, primary care staff in Sodo dis- 
trict, Ethiopia, have been trained to deliver packages of care for people with schizophrenia 
including prescription of antipsychotic medication, follow-up, limited adherence support, 
basic psychoeducation and community awareness-raising [ 29]. Psychoeducation refers to the 
education of people with mental illness to increase their knowledge and understanding of their 
treatment and illness. This facility based care constitutes treatment as usual in the control arm 
of the RISE trial, and will be delivered in conjunction with CBR in the intervention arm. 
The importance of intervention development prior to testing complex mental health inter- 
ventions is widely acknowledged, particularly in LMIC [30–33]. This work helps to design an 
intervention that is acceptable and feasible to both its recipients and those delivering it, and is 
ultimately more effective. The particular benefits include: 
• Ensuring the intervention is appropriate to local resources and health services structures [32, 
 34]. 
• Identifying contextually-mediated barriers to delivery [33]. 
• Ensuring the cross-cultural applicability and relevance [30]. 
• Getting buy-in from national and local stakeholders [30]. 
This paper summarises the formative research used to design an acceptable, feasible and 
sustainable CBR intervention that is likely to be effective for people with schizophrenia in Ethi- 
opia, to be tested in a pilot and subsequently in the RISE trial. At the outset we acknowledged 
two key challenges. First, how to develop a CBR intervention in a setting with few public sector 
mental health resources. Second, how to strike the balance between an intervention which is 
likely to be effective and one that might realistically be scaled up in the context of limited 
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1. Which components of CBR are likely to be effective at improving functioning for people 
with schizophrenia? 
2. Is CBR useful, acceptable and feasible from the perspective of people with schizophrenia 
and their caregivers? 
3. What health service structures exist and how can they support CBR? 
4. Is it possible to recruit, train and retain non-health workers to deliver CBR? 
5. What community resources are available and are they accessible to people with 
schizophrenia? 
6. Are community leaders willing and able to participate in CBR? 





This study used a range of qualitative and participatory methodologies in five phases from Sep- 
tember 2012 to March 2014. Intervention development was guided by a Theory of Change 
approach [35] in conjunction with the Medical Research Council framework for complex inter- 
ventions [36]. The Theory of Change map provides a graphic representation of the causal path- 
ways through which the RISE intervention is expected to achieve its impact [ 35]. The map 
includes (i) the final outcome (improved functioning in people with schizophrenia), (ii) inter- 
mediate outcomes that are needed to achieve the final outcome, (iii) interventions which are 
needed to move from one outcome to the next, (iv) assumptions (the conditions which the 
causal pathway needs in order to progress), (v) rationale for each link in the pathway and (vi) 
indicators (to evaluate whether each outcome is achieved). Assumptions articulated by the 
Theory of Change formed the research questions to be answered. We refined the map through- 
out the process as assumptions were tested and turned into rationale, or the intervention design 
was modified to fulfil assumptions. 
 
Ethics statement 
The London School of Hygiene & Tropical Medicine Research Ethics Committee (reference 
6408) and the Addis Ababa University College of Health Sciences Institutional Review Board 
(reference 039/13/PSY) granted ethical approval. Written informed consent was obtained from 
all participants in the in-depth interviews and focus group discussions. Only people with 
schizophrenia who had stable illness were invited to participate. Prior to conducting the inter- 
views the psychiatrist assessed the individuals’ decision-making capacity. Only individuals 
judged to have decision-making capacity were included; these individuals continued to the 
consent process. Verbal informed consent was obtained from all participants in the Theory of 
Change workshops and recorded in the workshop notes. Individual written informed consent 
was not sought from workshop participants as the workshops were a participatory planning 
process; the workshops were not audio-recorded; vulnerable groups, i.e. people with schizo- 
phrenia or caregivers, were not included in the workshops; and the workshop outputs were two 
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Phase 1: Identification of potential components of CBR for schizophrenia 
Objectives. (i) Identify potential components of CBR and their likely effectiveness and (ii) 
describe how components could improve functioning. 
Methods. A literature review of CBR for schizophrenia in LMIC was conducted. Other 
psychosocial interventions were also reviewed because CBR consists of many elements that 
have typically been evaluated separately. We reviewed resources from the WHO (CBR Guide- 
lines) [17], COPSI [37], Rehabilitation And Prevention Initiative against Disabilities (RAPID) 
project, and other similar projects. RAPID is an Ethiopian CBR project for children with dis- 
abilities. RAPID is a local collaborator on RISE and is affiliated with CBM, an international dis- 
ability and development organisation. Site visits and in-depth consultation with the RAPID 
management team were conducted. The collated information was used to create a draft Theory 




Phase 2: Situational analysis 
Objectives. (i) Describe the socio-demographic characteristics, health services and com- 
munity resources of Sodo and (ii) describe the situation of people with schizophrenia in this 
context. 
Methods. We drew on work conducted by the PRIME project in Sodo district, which has 
been described in detail elsewhere [33, 38– 40]. In brief it involved (i) reviewing a situational 
analysis, which comprised public domain data relating to population, health and social indica- 
tors; mental health policies and plans; mental health treatment coverage and district level ser- 
vices [38] (ii) reviewing resource mapping data collected using a semi-structured instrument to 
systematically quantify community assets, for example traditional healers and religious groups 
and [39] (iii) reviewing qualitative data on the acceptability and feasibility of task-sharing men- 
tal health services [33, 40]. In addition rich local data relating to prevalence [41], clinical course 
and outcome [1, 7, 10], disability [2], mortality [6, 42], access to health services [10], beliefs 
[43, 44], caregiver burden [3, 45], experiences of stigma [4, 5, 9] and use of traditional healers 
[43] relating to schizophrenia was reviewed. 
 
 
Phase 3: Evaluation of the feasibility of CBR 
Objectives. (i) Determine the feasibility of CBR components and delivery mechanisms 
and (ii) get local ‘buy-in’ for RISE. 
Methods. The scoping workshop and first Theory of Change workshop involved eight 
experts in CBR and mental health. The second Theory of Change workshop included twenty 
community leaders from Sodo, including representatives of microfinance, edir (traditional 
burial association), education, police, traditional healers and religious leaders. Each workshop 
lasted half a day; the expert workshops were facilitated in English and the community work- 
shop was facilitated in Amharic by an Ethiopian investigator (AF). At each workshop a large- 
scale (approximately 2 metres x 3 metres) draft Theory of Change map was presented to work- 
shop participants and the various components explained. The map was refined in real time by 
investigators by adding notes on colour-coded paper and linking arrows. Photographs were 
taken of the map at the end of each workshop to maintain a visual record of the discussion. In 
addition, detailed minutes were taken in English by an Ethiopian research assistant. Following 
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Phase 4: Evaluation of the acceptability of CBR 
Objectives. (i) Describe unmet needs of people with schizophrenia and (ii) determine the 
acceptability of CBR. 
Methods. We conducted 16 in-depth interviews and five focus group discussions (includ- 
ing 35 participants) with people with schizophrenia, caregivers, community and religious lead- 
ers, traditional healers, RAPID CBR workers, health extension workers and primary healthcare 
workers (see Table 1). Health extension workers are salaried community health workers 
engaged in health promotion and disease prevention. Participants were identified through the 
district health bureau (for staff), RAPID CBR project, and Butajira psychiatric outpatient clinic. 
Participants were purposively selected to ensure a spread of gender, work experience, type of 
community leader and functioning of people with schizophrenia. Topic guides covered key 
issues around acceptability and feasibility. The In-depth interviews and focus group discus- 
sions were conducted in Amharic by a male Ethiopian psychiatrist and a male Ethiopian PhD 
student (with a Psychology MSc). Both had experience in conducting interviews and discussion 
groups with people with schizophrenia and caregivers. The participants were contacted by tele- 
phone or face-to-face to invite them to participate; no potential participants refused to take 
part. The interviews were conducted at health centres and the research office in Butajira, a pri- 
vate room in Bui town, and the RAPID office in Adama. Participants were given information 
about the purpose of the study prior to the interviews, but no other relationship between the 
researchers and participants was established in advance. In-depth interviews lasted between 40 
and 60 minutes and focus-group discussions lasted between 60 and 120 minutes and all were 
audio-recorded. The investigator conducting the main analysis (LA) observed all interviews 
and focus groups. Debrief discussions with the interviewers were held immediately afterwards; 
initial impressions and observations were captured in field notes. No repeat interviews or par- 
ticipant checking was carried out. The audio-recordings were transcribed in Amharic, and 
then translated into English. A framework analysis was conducted; this approach is recognised 
as suitable for intervention development work as interviews are typically structured with clear 
a priori themes [46]. NVivo for Mac software was used to manage the data. A coding scheme 
was developed using a priori core themes based on the topic guide (e.g. ideal characteristics of a 
CBR worker); and subsequently sub-themes and new themes that emerged through reading the 
manuscripts. Two investigators indexed two transcripts using the codes developed. Discrepan- 
cies between applications of the coding scheme were discussed and adjustments were made 
where required. One investigator then indexed all transcripts using the final coding scheme. A 
matrix was created charting data relating to each theme against each participant. Finally, 
 
Table 1. In-depth interviews and focus group discussion participants. 
Stakeholder Number of in-depth 
interviews 
Number of focus group 
discussions 
 
People with schizophrenia (male) 3 0 
People with schizophrenia 
(female) 
2 0 
Caregivers (male) 1 1 (n = 8) 
Caregivers (female) 1 1 (n = 7) 
Community leaders (male) 7 0 
Health extension workers 0 1 (n = 8) 
Primary care workers 0 1 (n = 6) 
CBR workers 2 1 (n = 6) 
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themes were summarised and interpreted, noting associations between themes and patterns 
relating to participant characteristics (e.g. gender). Further interviews and focus groups were 
conducted until data saturation was reached. 
 
Phase 5: Synthesis of results to finalise intervention 
Objectives.  (i) Finalise CBR content and delivery and (ii) develop CBR training materials. 
Methods. A three-day intervention-planning workshop involved Ethiopian psychiatrists, 
the CBM West Africa mental health advisor, CBM Ethiopia director, RAPID manager, and the 
senior health administrator for Sodo. The synthesised findings of Phases 1 to 4 were presented 
to participants, who decided the detailed content and structure of the intervention. The final 
Theory of Change map is presented in Fig 1. 
 
Results 
The following section details how the research questions were answered using the different 
methods, and how these findings contributed to the final intervention (see S1 Table for details). 
 Table 2 summarises the key themes generated from the in-depth interviews and focus group 
discussions (Phase 4). 
 
1. Which components of CBR are likely to be effective at improving 
functioning for people with schizophrenia? 
Potential components of CBR for schizophrenia were listed according to the CBR pillars 
(health, social, livelihood, empowerment and education- see Table 3); whilst many relate to 
health, other pillars were also represented. The strongest evidence related to psycho-education 
[47–52], family intervention [23, 24, 53, 54] and adherence support [55, 56]. Multi-component 
interventions were effective, but it was difficult to elucidate their ‘active ingredient/s’ from the 
results [19, 20, 26]. We took into account whether potential CBR components were likely to be 
effective for the ‘difficult to treat’ group who will participate in the RISE trial. Novel compo- 
nents of CBR for schizophrenia included family intervention, stress and anger management 
and dealing with distressing symptoms (e.g. hallucinations and delusions). A schema of how 
CBR components could improve functioning was incorporated into the Theory of Change map 
(Fig 1). Many components may act in synergy, and also through intermediate outcomes and 
positive feedback loops. For example rehabilitation focused on returning to farm work, as well 
as directly improving functioning, may improve the ability of individuals to pay for medication, 
which in turn improves symptoms and therefore functioning. Support with medication adher- 
ence is also likely to improve symptoms; together with a family intervention this will reduce 
the need for physical restraint, which would also lead to return to previous functional roles. 
There was strong support for community mobilisation from all stakeholders. Disability 
arises due to both illness and societal factors [ 57] so an intervention addressing both elements 
is indicated. There was consensus that community leaders have a powerful influence on the 
views of the community and are gatekeepers to community resources needed for CBR (“The 
community won’t believe in things that the leaders don’t believe in” (FGD 03, health extension 
worker)). This was an important finding given the strong influence of stigma on the experi- 
ences and social functioning of people with schizophrenia. Structured community mobilisation 
was therefore prioritised to maximise the effectiveness and sustainability of CBR. As shown on 
the theory of change map, identification and mobilisation of community resources are interme- 



















































Fig 1. RISE Theory of Change map. 
doi:10.1371/journal.pone.0143572.g001 
 
















































2. Is CBR useful, acceptable and feasible from the perspective of people 
with schizophrenia and caregivers? 
People with schizophrenia and caregivers were found to have a range of unmet needs and prob- 
lems. Issues included conflict within families, being estranged from friends, difficulty doing 
housework, farm work and business and problems with self-care. Many participants with 
schizophrenia and caregivers reported experiences of stigma and other types of participants 
were aware it was a common occurrence. Instances included being called names, being laughed 
at or gossiped about, losing friends, being discouraged from participating in social life, and not 
being trusted in the workplace or in other settings. One male caregiver reported, “No institu- 
tion, no organization invites persons with mental illness to participate... because they are people 
with problems, saying that they will ruin things.. . they will not perform the work properly" 
(FGD 01, male caregiver). Another caregiver explained, “They won’t accept their word. Even if 
he [her son with schizophrenia] speaks the truth, they would say, ‘he is a patient, don’t say any- 
thing back’. He is a patient. Now they say, ‘is he possessed by the devil?’” (FGD 02, female care- 
giver). Problems with participating in conventional community activities, for example drinking 
coffee with family and neighbours, attending church or mosque and attending weddings and 










Table 2. Summary of findings from in-depth interviews and focus group discussions. 
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Research question Theme Findings 
 
Which components of CBR are likely   to be Necessity of community Community leaders have powerful influence on the community’s 
effective? mobilisation element beliefs 
Community leaders are gatekeepers to community resources 
Is CBR useful, acceptable and feasible from the 
perspective of people with schizophrenia and 
caregivers? 
Current problems and needs Family conflict 
Estranged from friends and neighbours 
Difficulty doing housework, farm work and business 
Problems with self care 
Stigma and discrimination 
Problems participating in community activities 
High caregiver burden 	 CBR content CBR perceived as acceptable and useful overall 
Caregivers and community leaders thought returning to work as 
central to regaining functional role and economic status; people 
with schizophrenia concerned about stress. 
Personal experiences of physical restraint or awareness of the 
practice amongst most participants; best approach to address this 
felt to be improved access to mental healthcare 	 CBR delivery Most participants preferred home visits 
Some participants preferred CBR workers the same gender as 
participants; others had no preference 
Desirable characteristics of CBR workers included being caring, 
understanding and knowledgeable, and having a good 
understanding of the local community 
Is it possible to recruit, train and retain field 
workers to deliver CBR? 
Willingness of CBR workers Motivation to work with people with schizophrenia. 
Fears the work could be risky or stigmatizing 	 Ability of CBR workers Confident of ability to do work. 
Importance of field training, top-up training and peer supervision 
stressed 
What community resources are available   in Sodo Accessibility of community Problems accessing community resources due to stigma,  
and are they accessible to   people with resources problems with social interactions, lack of motivation and being 
schizophrenia?  symptomatic. 	 Role of edir (traditional burial 
association) 
Suggested role of edir included financial/material support, 
awareness raising, higher threshold for exclusion of people with 
schizophrenia when not contributing 
Are community leaders willing and able to 
participate in CBR? 
Willingness of community Community leaders report sense of responsibility to support 
people with schizophrenia. 
Caregivers sceptical that support will be available. 	 Willingness of traditional or 
religious healers to 
participate 
Healers reported willingness to signpost to health centre/ 
medication. 
Some reports of healers warning against medication use. Mixed 
views as to whether healers would receive education and change 
practices. 	 Willingness to work with 
either gender 
Community leaders state they are willing to work with CBR 















Table 3.  Potential components of community-based rehabilitation for schizophrenia. 
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HEALTH SOCIAL LIVELIHOOD EMPOWERMENT EDUCATION 
 
Psycho-education ++ Support with self-care + Facilitating access to social 
protection + 
Addressing human rights - Facilitating access to adult 
education - 
Adherence support ++ Social skills training + Supporting return to work + Individual stigma reduction 
strategies - 
Family intervention ++ Supporting return to social 
activities + 
Facilitating access to 
microfinance + 
Self-help initiatives + 




Support for distressing 
symptoms + 
Support accessing health 
services + 
Stress and anger 
management + 
 
Strength of evidence in literature review: 
(++) Strong evidence 
(+) Weak evidence/ part of multi-component study 




including side effects of medication, being unwell or unmotivated, having poor social skills, 
and stigmatising attitudes of community members. The range of needs highlighted the require- 
ment for detailed needs assessments for participants. CBR would then be tailored accordingly, 
as opposed to a ‘one size fits all’ approach. Focusing on the participants’ expressed needs was 
perceived to be an important approach for maintaining engagement in the programme. 
Caregivers were found to have high burden relating to financial problems (often due to 
costs of treatment), fear for personal safety, stigma and problems with social life. One caregiver 
said, “We hide knives and tools from him because we are scared of him... Just in case he got 
upset all of a sudden.. .He might kill someone or he might destroy or burn someone’s property” 
(IV02, female caregiver). Several reported that they had become ill through caring: “We all 
became sick because of him” (IV03, male caregiver). In light of this, guidance on assessing and 
addressing caregiver problems was added to the intervention. 
All stakeholder groups viewed CBR as an acceptable and useful approach. First, because 
medication alone did not solve all problems; psychosocial support and rehabilitation were also 
needed. Second, because external ‘expert’ advice was likely to have greater influence on individ- 
uals with schizophrenia than advice from family members. Third, because an individual’s 
recovery could benefit the whole community, particularly if they could return to work. Finally, 
CBR was seen as empowering (“[CBR] is essential for people with mental illness.. ..to live on 
equal bases in terms of ways of thinking and attitude” (FGD 01, male caregiver). 
For many participants, support returning to work was crucial for improving functioning, 
economic status and reducing family burden. However there were mixed views from people 
with schizophrenia. One participant was keen to receive a business loan, whilst two others only 
wanted simple work, and found dealing with money stressful. Most people in Sodo are subsis- 
tence farmers, there is limited formal employment and no vocational rehabilitation facilities. 
Accordingly, it was decided that vocational rehabilitation, whilst important, would typically 
focus on developing skills required for returning to farm work or daily labouring. Due to con- 
cerns that microfinance (such as cooperative savings and loans schemes) may increase stress in 
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component from the RISE intervention. There was also particular backing for psycho-educa- 
tion, family support and support with adherence and accessing health services. Furthermore, 
the qualitative findings indicated that specific components were needed to address problems 
with day to day functioning (for example dressing independently) and participation in com- 
munity activities (to include support with regaining specific social skills). 
Some participants perceived self-help groups as useful for support and information sharing. 
There were examples of female caregivers and people with schizophrenia already meeting to 
discuss their problems. Together these findings suggested self-help initiatives could be a useful 
component, even without a savings and loans element. 
Most participants were aware of physical restraint of people with schizophrenia, with some 
speaking from personal experience. The reasons for restraint included protecting the individual 
(from themselves or others), protection of others, as a means to transport the person to the 
health centre, and as a means to force the individual to take medication. 
Consensus across stakeholder groups was that the best way to reduce chaining was to 
increase access to treatment. Community leaders felt the family should be educated about the 
harmful effects of chaining. There was concern amongst community leaders that unchaining 
may put other community members at risk. The decision was made to focus on avoiding chain- 
ing through access to treatment. The CBR worker should not instigate unchaining, but should 
work with the supervisor and health centre to ensure unchaining happens safely. In addition 
we would include pragmatic advice on how to restrain in a safe and dignified way, when it was 
needed as a last resort. 
There are 49 herbalists, 21 tanqway (‘sorcerers’) and 27 holy water sites across the district 
[39]. Holy water, which is used for bathing or drinking at sites associated with the Orthodox 
Church, is believed to have curative properties. Holy water use reflects a prevailing belief in 
Ethiopian culture that severe mental illness is attributable to supernatural forces, such as pos- 
session by spirits or the shadow cast by the ‘evil eye’ [43, 44, 60]. The use of holy water is sanc- 
tioned by the dominant religious authorities. A visit to a holy water site may last from days to 
months. Whilst the Orthodox priests based at these holy water sites may provide spiritual guid- 
ance to people with mental illness, they do not typically take on an active caring role with indi- 
viduals. However attendants based at holy water sites often house and feed holy water 
attenders for a fee paid by the family. In the current study holy water was used by several peo- 
ple with schizophrenia, often alongside taking medication. Primary care workers and commu- 
nity leaders also perceived tanqway to be commonly used. Previous research showed that 37% 
of people with schizophrenia in this area attend a traditional healer [7] and 30.9% of those 
obtaining treatment at Ammanuel Psychiatric Hospital in Addis Ababa had first sought help 
from priests or holy water sites [61]. There were experiences of medication being both encour- 
aged and discouraged by holy water priests, and a few experiences of being restrained or beaten 
for refusing to take holy water. Education about the risks and benefits of holy water and tradi- 
tional healing was included, with the focus on encouraging the use of medication alongside tra- 
ditional treatments. 
The high levels of poverty and long distances to roads, health centres and public transport 
meant participants would have difficulty travelling for CBR. The majority therefore wanted 
home visits, rather than visiting the health centre. There were no concerns about increased 
stigma resulting from home visits. Two people with schizophrenia who preferred CBR visits at 
the health facility wanted to be more active. CBR would therefore be delivered at home as stan- 
dard, with health facility visits offered as an alternative in order to maximise engagement. Peo- 
ple with schizophrenia and caregivers reported they could be flexible about the timing of visit. 
Nevertheless the importance of fitting around the participants’ schedules was emphasised, in 
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Several caregivers and community leaders felt that the gender of the CBR workers did not 
matter; it was their skills that would be important. Others felt that CBR workers should be the 
same gender as their clients, as this would improve their relationship. It was decided that CBR 
workers of both genders would be recruited, whilst acknowledging that gendered allocation of 
CBR workers to participants would not be possible due to the cluster design of the RISE trial. 
Desirable characteristics of CBR workers included being caring, understanding and knowl- 
edgeable, and having a good understanding of the local community. CBR workers would there- 
fore be high school completers recruited from the immediate area. CBR worker competence 
evaluation would include communication skills. 
 
 
3. What health service structures exist and how can they support CBR? 
Primary care is delivered through eight health centres, staffed by health officers and nurses. 
The district’s first hospital is under construction. Most kebeles (sub-districts) are covered by 
one or two health extension workers. Health care costs are largely out-of-pocket with a free 
waiver available for the very poorest [38]. In mid-2014 primary care staff were trained in men- 
tal health diagnosis and treatment by PRIME. The health extension workers initially repre- 
sented a potential workforce to deliver CBR and the health centre staff represented potential 
collaborators. However it was ultimately decided CBR should be delivered by CBR workers, 
recruited and trained specifically for RISE, rather than health extension workers. The rationale 
was that HEWs would not have time to deliver CBR on top of their usual duties. In addition 
there were five kebeles without a health extension worker and concerns about further drop- 
outs. There was consensus that CBR should be linked to health centres but that primary care 
staff would have minimal capacity to support rehabilitation. Two RISE supervisors will cover 
eight CBR workers, using one-to-one supervision, group supervision and unannounced 
observed home visits. 
 
 
4. Is it possible to recruit, train and retain non-health workers to deliver 
CBR? 
Community leaders and experts predicted difficulty recruiting CBR workers willing to work 
with people with schizophrenia. A minority were concerned that CBR workers would not be 
able to provide psychosocial support. However, CBR workers (for physical disabilities), and 
health extension workers were motivated to do the work, stating it would be rewarding and 
clearly needed. Yet there were also fears that the work could be dangerous or stigmatizing for 
CBR workers. These concerns underlined that adequate safety procedures for CBR workers 
were an essential intervention for CBR to succeed (including risk assessment, provision of 
mobile phones, training to deal with challenging situations, and, where a risk is identified, joint 
visits with the supervisor), whilst conveying a balanced sense of the risks associated with work- 
ing with people with schizophrenia. It was decided to employ at least one male supervisor to 
maximise the safety of CBR workers. 
Health extension workers and CBR workers were confident that with training they could 
undertake CBR work for schizophrenia, emphasising that the core skills of CBR workers are 
generic. They stressed the importance of practical training, shadowing existing CBR workers, 
and top-up training. Both one-to-one and group supervision were recommended, with the lat- 
ter being particularly helpful for overcoming difficulties. The need for physically fit CBR work- 
ers was highlighted as there were no resources for car travel. Ability to walk long distances was 
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5. What community resources are available and accessible to people 
with schizophrenia? 
Each kebele in Sodo district has churches, religious groups, women and youth associations. 33 
kebeles have a government literacy programme, and most have a government microfinance ini- 
tiative. There are no mental health users groups or disabled people’s organizations [ 39]. The 
rich community resources suggested that CBR workers should do resource mapping when they 
first start work in a kebele. There were mixed views as to whether people with schizophrenia 
have problems accessing existing community resources. All kebeles have several edir. Although 
edir is ostensibly a burial association, there was agreement that it is “the most important com- 
munity mobilizing agent." (IV08, edir leader) and should be engaged as a conduit for social 
inclusion and stigma reduction. Possible examples of community mobilisation were identified, 
including church leaders vocalising public support for an individual or assisting the family to 
take them to the health facility; and edir groups or wealthy individuals mobilising funds from 
community members to provide food or shelter for people with mental illness. However there 
were mixed views about edir’s potential role as a provider of social protection or material sup- 
port. The intervention was therefore modified to indicate that financial support from edir 
should arise organically and not be demanded by the CBR worker. 
 
6. Are community leaders willing and able to participate in CBR? 
There were conflicting views as to whether community leaders would use their authority to 
support CBR without personal benefits. This was recognised as a key assumption to fulfil in 
order for the intervention to succeed. Female caregivers, based on their previous experiences, 
were sceptical that community leaders would provide support, whilst community leaders them- 
selves described a sense of responsibility and were keen to collaborate. The importance of first 
raising awareness amongst community leaders was highlighted, with emphasis to be made on 
the benefits for the whole community of an individual’s recovery. The success of community 
mobilisation would then be reliant on community members taking ownership of the issue and 
identifying for themselves the ways they could help people with schizophrenia. There were 
mixed views as to whether holy water priests would be receptive to education about schizo- 
phrenia and the extent to which this would change their practices. It was decided that engage- 
ment with holy water priests and traditional healers would be instigated only where the family 
perceived this as useful. Concerns were raised as to whether community leaders would engage 
with female CBR workers, but community leaders themselves reported that skills were more 
important than gender. 
 
7. How can the positive effects of CBR be sustained? 
RAPID uses a combination of skills transfer to caregivers, parent groups and CBR committees 
(consisting of leaders from a range of sectors) to ensure the positive effects of CBR continue 
once the CBR workers had left the area. As it would be unfeasible to create new structures to 
ensure sustainability, it was decided that edir groups should be encouraged to take ownership 
of CBR. Family support groups were incorporated in the intervention and skills transfer to 
caregivers was highlighted as a key principle of CBR. 
 
Summary of final RISE intervention 
The focus of the RISE CBR intervention will be on the individual developing the skills and con- 
fidence to perform their previous or desired roles and activities. These may relate to family life, 
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the individual’s strengths. Fig 2 summarises the final intervention structure. Basic counselling 
and problem solving skills will be employed by CBR workers to deliver the intervention. The 
intervention is delivered in three phases. In Phase 1, lasting one to two months, there are 
weekly home visits and the focus is on engagement with the family and addressing core needs 
through compulsory modules such as “Understanding Schizophrenia”. Following a needs and 
risk assessment, structured goal setting will be used to support individuals to select appropriate 
goals from a pre-defined list. In addition to four core modules, the goal selection will determine 
which additional CBR components the individual will receive. In Phase 2, lasting approxi- 
mately five to six months, home visits are every two weeks and address the specific needs of the 
individual through optional modules such as “Getting Back to Work”. In Phase 3, lasting 
approximately four months, the emphasis is on preventing relapse as well as maintaining the 
progress made towards addressing specific needs. The three intervention phases reflect the 
changing needs of participants over 12 months. The transition between phases is conditional 
on achievement of goals rather than specific time points. 
Community mobilisation work will run alongside family-based components. Community 
mobilisation involves identifying local community resources and leaders, awareness-raising 
meetings at existing community groups (for example women’s saving groups) and targeted 
meetings with community leaders addressing specific needs of participants (for example identi- 
fying sources of food or financial support, or encouraging patients to attend the health centre). 
Whilst support with medication adherence is an important component, CBR workers will not 
prescribe or deliver medication. Indeed participants who are unable or unwilling to take anti- 
psychotic medication will nevertheless continue CBR and be supported to achieve goals related 
to functioning, which is the primary aim of the intervention. The five-week training pro- 
gramme for CBR workers will include 50% practical and 50% fieldwork, and will follow a train- 




This study is a systematic and theory-driven effort to design a CBR intervention for schizo- 
phrenia in a resource-poor setting. This preparatory work aimed at designing the RISE inter- 
vention is an innovative attempt to tailor CBR’s capacity to promote inclusion and improve 
access to essential services to the needs of people with schizophrenia. In doing so it aims to 
bridge the gap between health services and a more community-oriented development model of 
disability [34]. Whilst integration of mental health into existing CBR programmes has typically 
involved in-depth consultation work, this has not usually been theory-driven. The RISE CBR 
intervention has important differences compared to other models of community care for 
schizophrenia in LMIC. First, distinct from other interventions, such as COPSI [ 26] and a 
South African ACT programme [ 22], there is a substantial community mobilisation element. 
Our results indicate that community participation is likely to be essential for improving social 
inclusion, as well as having a role in improving medication adherence, reducing experiences of 
stigma and improving economic status. Utilising the CBR model, in which community mobili- 
sation is key, therefore represents a major strength of the RISE intervention. Second, there is 
no collaboration with mental health specialists [30, 33]. This reflects the reality in this setting 
that the majority of care for people with schizophrenia is delivered by primary care staff, who 
have themselves only recently been trained in mental health. Third, there is a more structured 
approach to setting goals for individuals and selecting intervention components compared to 
other interventions [26]. 
We compromised on immediate scalability to construct a feasible intervention. The use of 
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resources are required to scale up CBR, and as such RISE is a proof of concept study. This was 
a pragmatic approach given the widespread recognition that scaling up of mental healthcare 
cannot be done without extra resources. The RISE intervention is designed to be scalable with 
limited resources, for example only people with schizophrenia who are still unwell or disabled 
after six months access to facility-based care are included. The RISE trial will determine 
whether this intervention is cost-effective and therefore a potentially suitable investment for 
governments and other funders including the Ethiopian Ministry of Health. The collaboration 
between the Ministry of Health and PRIME (in which RISE is nested) could potentially pave 
the way for the scale up of CBR for schizophrenia. Furthermore, by utilising CBR workers 
(rather than existing health workers) and collaborating with CBM we have designed an inter- 
vention that meets the needs of, and is compatible with, CBR projects for other disabilities. 
This will provide evidence for integration of mental health into the large network of existing 
CBR projects run by NGOs. 
This study addresses a criticism of global mental health research by developing a socially 
and culturally relevant psychosocial intervention using participatory methods [62]. The Theory 
of Change approach allows assumptions and barriers to be articulated and tested using a range 
of research methods. The Theory of Change map gives a visual record of modifications to the 
intervention on the basis of the research findings. A set of indicators has been developed, 
including trial outcomes and process data. This gives us a theoretical framework that we can 
later use to identify which are the most important components of CBR as part of the formal 
evaluation in an RCT, allowing us to refine an effective intervention for scaling up. 
There may have been social desirability bias, particularly from community leaders, as there 
may be political pressure to express support of government initiatives. As PRIME, in which 
RISE is nested, is a collaboration with the Ethiopian Ministry of Health, community leaders 
may have felt compelled to champion CBR. This could explain their different opinion regard- 
ing community support compared to female caregivers, who are not susceptible to the same 
pressures. As the investigators are invested in the RISE project it is possible this led to a biased 
interpretation of the qualitative data, emphasising a favourable opinion of CBR amongst par- 
ticipants. While no meaningful ownership of the Theory of Change map can be claimed by 
stakeholders outside of the workshops, those who participated represented relevant stakehold- 
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Extensive formative research using a variety of methods nested within a Theory of Change 
framework has enabled the design of a culturally appropriate complex mental health interven- 
tion that is acceptable and feasible to service users and providers. This CBR intervention will be 
finalised in a pilot and then tested in a cluster-randomised trial to determine its effectiveness 
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	Individual		 		 CBR	worker		 		 Date		 		
Start	time		 		 Finish	time		 		 		
Phase	(tick)		






































































































































































































































































































































































































































































































	 	 Method	 Session	 Trainer	
Week	1	 	























Friday	AM	 Classroom	 Goal	Setting	I	 Psychiatrist	
Goal	setting	II	
Friday	PM	 Assessment	 	 RISE	team	
Week	2	 	
Monday	AM	 Classroom	 Intro	to	RAPID	 RAPID	CBR	worker/	
supervisor	Monday	PM	 Practice	in	field	 Needs	assessment	and	goal	setting	







Thursday	AM	 Discussion	 Daily	functioning	&	Improving	physical	health	 RAPID	supervisor	
Thursday	PM	 Classroom	 Family	support	groups	
Dealing	with	stress	and	anger	
Friday	full	day	 Practice	in	field	 Family	groups	&	Dealing	with	stress	and	anger	 RAPID	CBR	worker/	
supervisor	
Saturday	AM	 Discussion	 Family	groups	&	Dealing	with	stress	and	anger	 RAPID	supervisor	
Saturday	PM	 Classroom	 Community	mobilisation	I	and	II	 	
Sunday	AM	 Classroom	 Community	life	 RAPID	supervisor	
Getting	back	to	work	
Week	3	 	 	 	
Monday	AM	 Practice	in	field	 Community	mobilisation	 RAPID	CBR	worker/	
supervisor	



































Friday	full	day	 Day	off	 	 	
Saturday	AM	 Discussion	 Family	intervention	&	distressing	symptoms	 Psychiatrist	
Saturday	PM	 Classroom	 Taking	control	of	your	illness	 	
Dealing	with	stigma	
Week	5	 	
























































7.	 Ask	the	group	what	recovery	might	mean	to	Yosef	 Flip	chart	 10	
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	 This	pilot	study	was	conducted	between	December	2014	and	December	2015.	The	participants	were	ten	people	with	schizophrenia	and	their	families	living	in	four	sub-districts	of	Sodo.	Only	one	participant	per	CBR	worker	was	selected	because	this	was	perceived	to	be	an	appropriate	initial	workload	for	the	newly	trained	CBR	workers,	as	well	as	a	suitable	sample	size	for	the	in-depth	analysis	planned.	The	four	sub-districts	were	selected	for	convenience;	they	were	all	linked	to	the	health	centre	that	saw	the	earliest	implementation	of	mental	health	into	primary	care,	and	cohort	study	recruitment,	by	PRIME.	In	the	selected	sub-districts,	the	intervention	coordinator	assessed	consecutive	PRIME	cohort	recruits	for	RISE	pilot	eligibility	by	reviewing	data	routinely	collected	at	PRIME	baseline	(see	Appendix	D	(i)).	There	were	no	specific	exclusion	criteria.	Participants	meeting	all	of	the	following	criteria	were	included:		 1) Participant	in	PRIME	cohort	study		 2) Resident	in	sub-district	for	>6	months	and	no	immediate	plans	to	leave	the	sub-	district		 3) Has	a	primary	caregiver	who	is	willing	to	participate	in	the	study		 4) Age	≥18	years		 5) Diagnosis	of	schizophrenia	spectrum	disorder	(schizophrenia,	schizoaffective	disorder	or	schizophreniform	disorder)	using	DSM-IV	criteria	(assessed	using	the	Operational	Criteria	for	Research	(OPCRIT)	[4])	[5]	and		 6) Evidence	of	enduring	or	disabling	illness	demonstrated	by	one	or	more	of	the	following:		 (i) Brief	Psychiatric	Rating	Scale	–	Expanded	version	(BPRS-E)	score	≥52	[6]		 (ii) 36-item	WHODAS	2.0	score	≥35	[7]	
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IDIs	 FGDs	 IDIs	 FGDs	
Men	with	schizophrenia	 4	 0	 5	 0	
Women	with	schizophrenia	 3	 0	 3	 0	
Male	caregivers		 1	 0	 1	 0	
Female	caregivers		 7	 0	 6	 0	
CBR	supervisors		 2	 0	 2	 0	
CBR	workers	 1	 2	(n=10)	 0	 2	(n=10)	
Health	officers	 2	 0	 0	 0	
Community	members		 0	 0	 3	 0	














































1		 12	 22	 5/7	(71.4)	 8/11	(73)	 1	 2	
2	**	 12	 21	 5/5	(100)	 4/9	(44)	 0	 2	
3	**	 10***	 17	 5/5	(100)	 2/10	(20)	 0	 1	
4	 8	 19	 4/5	(80)	 1/8	(13)	 3	 2	
5		 12	 17	 5/5	(100)	 8/9	(89)	 10	 1	
6		 11	 19	 4/4	(100)	 6/8	(75)	 0	 0	
7		 12	 24	 7/7	(100)	 8/8	(100)	 5	 1	
8		 11	 27	 7/7	(100)	 7/11	(64)	 4	 4	
9		 12	 23	 4/5	(80)	 6/9	(67)	 1	 1	
10		 12	 22	 6/7	(85.7)	 5/6	(83)	 0	 2	















































































































































































Disability	(WHODAS	total)	 Clinical	global	impression	 Depression	(PHQ-9	total)	 Alcohol	use	(AUDIT	total)	
0	m	 6	m	 12	m	 0	m	 6	m	 12	m	 0	m	 6	m	 12	m	 0	m	 6	m	 12	m	
1	 15.2	 0	 59.4	 Missing		 2	 4	 2	 3	 9	 7	 15	 10	
2	*	 70.9	 79.4	 70.0	 7	 5	 5	 11	 9	 2	 0	 2	 0	
3	*	 58.3	 93.8	 Participant	died		 4	 7	 Participant	died		 13	 19	 Participant	died		 0	 0	 Participant	died		
4	 45.7	 20.2	 2.6	 4	 2	 1	 13	 5	 13	 5	 5	 7	
5	 61.0	 51.6	 21.5	 3	 3	 4	 10	 12	 8	 22	 13	 2	
6	 26.0	 12.8	 Participant	refused		 5	 2	 Participant	refused		 15	 2	 Participant	refused		 27	 4	 Participant	refused		
7	 24.2	 28.9	 0	 6	 4	 2	 4	 11	 1	 3	 6	 4	
8	 62.8	 8.2	 14.0	 7	 1	 2	 12	 1	 4	 0	 16	 3	
9	 41.9	 3.8	 0	 6	 3	 2	 6	 0	 1	 4	 4	 0	












































0m	 6m	 12m	 0	m	 6	m	 12	m	 0m	 6m	 12m	 0	m	 6	m	 12	m	
1	 3	 1	 1	 2	 0	 0	 Yes	 No	 Yes	 35	 48	 59	
2	*	 2	 3	 1	 0	 3	 0	 No	 No	 No	 69	 56	 47	
3	*	 1	 0	 Participant	died		 2	 0	 Participant	died		 No	 No	 Participant	died		 43	 21	 Participant	died		
4	 0	 2	 2	 29	 11	 7	 No	 No	 No	 37	 19	 22	
5	 1	 3	 2	 35	 34	 24	 Yes	 No	 No	 Missing		 27	 33	
6	 1	 0	 Participant	refused		 1	 0	 Participant	refused		 Yes	 No	 No	 61	 26	 Participant	refused		
7	 0	 2	 3	 0	 0	 0	 No	 No	 No	 37	 21	 36	
8	 0	 3	 0	 4	 4	 0	 No	 Yes	 No	 70	 27	 28	
9	 0	 3	 1	 0	 0	 0	 No	 No	 No	 56	 16	 16	




























































































































































































































































































































































































































































































































































Assumption	 Main	findings	 Adjustments	to	intervention	 Conclusion	
Research	question	3:	Can	the	RISE	CBR	intervention	have	an	impact	and	if	so,	how?	
3a:	CBR	can	 Quantitative:	Substantial	improvements	in	disability,	symptoms,	 Envisage	that	adjustments	to	improve	acceptability	 Keep	as	assumption.	
improve	 alcohol	use,	depression,	discrimination	and	caregiver	burden	over	the	 and	feasibility	will	lead	to	improvements	in	impact.	 Monitor	in	trial	
functioning	in	 pilot	period.	 	 (quantitative)	as	randomised	
people	with	 Qualitative:	Increased	understanding	about	mental	illness	preceded	 	 evaluation	required	
schizophrenia	 increased	family	support	and	access	to	healthcare.	This	led	to	 	 		 increased	functioning	by	improving	symptoms,	decreasing	 	 		 stigma/abuse	and	social	inclusion	and	increasing	income.	Improved	 	 		 livelihood	most	important	outcome	for	many.	Increased	hope	and	 	 		 self-esteem	underpinned	and	sustained	functioning	progress.	Overly	 	 		 ambitious	goals	in	some	cases.	 	 	
3b:	A	community	 Process:	Improved	attitudes	and	knowledge	from	awareness-raising	 No	major	adjustments.	 Assumption	shown	to	be	
mobilisation	 led	in	some	cases	to	signposting	other	people	with	schizophrenia	to	 	 correct	and	converted	to	
approach	is	 health	centre.	Tangible	support	facilitated	for	4	participants	 	 rationale.	Monitor	specific	
required	in	 (medication,	housing,	moral/spiritual	support,	food).	Financial	 	 aspects	in	trial	(qualitative	
addition	to	 support	from	community	was	only	available	in	urban	area	for	people	 	 and	process)	
home-based	care	 with	schizophrenia	with	obvious	needs.	 	 	
3c:	Family	 Process:	1	group	set	up-		3	meetings.	 Family	support	groups	were	designated	as	an	 Keep	as	assumption	and	
support	groups	 Qualitative:	One	woman	with	schizophrenia	found	it	relieved	stress.	 optional	CBR	component	depending	on	the	wishes	of	 monitor	in	trial	(qualitative	
are	perceived	to	 Groups	not	set	up	as	too	few	participants;	did	not	want	to	discuss	 participants	in	each	sub-district.	 and	process)	
be	useful	despite	 problems;	too	ill	to	attend.	 	 	
not	having	 	 	 	
savings	and	loans	 	 	 	












































































































































































































































		 		 		 ✓		 Supervisor	logbooks		
All	CBR	workers	have	minimum	of	12	face	to	face	supervision	
sessions		
		 		 		 ✓		 Supervisor	logbooks		
CBR	workers	attend	80%	group	supervision	sessions		 		 		 		 ✓		 Supervisor	logbooks		
Supervision	perceived	to	be	useful	and	of	appropriate	
frequency		






90%	participants	receive	all	core	modules	in	first	3	months		 		 		 		 ✓		 Participant	logbooks		
Participants	undertake,	on	average,	90%	modules	indicated	
by	goal	setting		
		 		 		 ✓		 Participant	logbooks		
All	participants	continue	to	receive	CBR	visits	for	12	months		 		 		 		 ✓		 Participant	logbooks		
Participants	receive	approximately	22	home	visits	over	12	
months	(ideal	CBR	receipt)		
		 		 		 ✓		 Participant	logbooks		
Participants	receive	10	or	more	home	visits	over	12	months	
(minimum	adequate	CBR	receipt)		
		 		 		 ✓		 Participant	logbooks		
On	going	family	support		 Continuing	Care	Form	completed	for	all	participants	by	12	
months		
		 		 		 ✓		 Participant	logbooks		
Family	and	CBR	worker	feel	family	are	able	to	continue	
support	by	12	months		






































































	 	 ✓ 	 Endline	CBR	worker	FGD,	participants	
IDI	
Medication	fee	waiver	obtained	when	required	 	 	 ✓ 	 Endline	CBR	worker	FGD	
Reported	ability	to	pay	for	anti-psychotic	medication	directly	
or	indirectly	attributable	to	CBR	


































































	 	 ✓ 	 Endline	CBR	worker	FGD,	participants	
IDI	
Greater	BMI	in	intervention	arm	compared	to	control	arm	 	 ✓ 	 	 BMI	12	months	
Lower	AUDIT	scores	in	intervention	arm	compared	to	control	
arm	
	 ✓ 	 	 AUDIT	12	months	
Reported	attendance	to	facility	for	physical	health	directly	or	
indirectly	attributable	to	CBR	























































	 ✓ 	 	 	 BPRSE,	CGI	and	PHQ-9	12	months	
Fewer	relapses	in	last	6	months,	measured	by	LCS	and	LIFE,	in	
intervention	arm	compared	to	control	arm	

























✓ 	 	 	 	 WHODAS	12	months	
Perceived	improvement	in	functioning	directly	or	indirectly	
attributable	to	CBR	
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Intervention for people with Schizophrenia 
in Ethiopia (RISE): study protocol for a 
cluster randomised controlled trial 
Laura Asher1,2*, Mary De Silva1, Charlotte Hanlon2,3, Helen A. Weiss4, Rahel Birhane2, Dawit A. Ejigu5, 
Girmay Medhin6, Vikram Patel1,7,8  and Abebaw Fekadu2,9 
 
Abstract 
Background: Care for most people with schizophrenia is best delivered in the community and evidence-based 
guidelines recommend combining both medication and a psychosocial intervention, such as community-based 
rehabilitation. There is emerging evidence that community-based rehabilitation for schizophrenia is effective at 
reducing disability in middle-income country settings, yet there is no published evidence on the effectiveness in 
settings with fewer mental health resources. This paper describes the protocol of a study that aims to evaluate the 
effectiveness of community-based rehabilitation as an adjunct to health facility-based care in rural Ethiopia. 
Methods: This is a cluster randomised trial set in a rural district in Ethiopia, with sub-district as the unit of 
randomisation. Participants will be recruited from an existing cohort of people with schizophrenia receiving 
treatment in primary care. Fifty-four sub-districts will be randomly allocated in a 1:1 ratio to facility-based care plus 
community-based rehabilitation (intervention arm) or facility-based care alone (control arm). Facility-based care 
consists of treatment by a nurse or health officer in primary care (antipsychotic medication, basic psychoeducation 
and follow-up) with referral to a psychiatric nurse-led outpatient clinic or psychiatric hospital when required. Trained 
community-based rehabilitation workers will deliver a manualised community-based rehabilitation intervention, with 
regular individual and group supervision. We aim to recruit 182 people with schizophrenia and their caregivers. 
Potential participants will be screened for eligibility, including enduring or disabling illness. Participants will be recruited 
after providing informed consent or, for participants without decision-making capacity, after the primary caregiver 
gives permission on behalf of the participant. The primary outcome is disability measured with the 36-item WHO 
Disability Assessment Schedule (WHODAS) version 2.0 at 12 months. The sample size will allow us to detect a 20 % 
difference in WHODAS 2.0 scores between treatment arms with 85 % power. Secondary outcomes include change in 
symptom severity, economic activity, physical restraint, discrimination and caregiver burden. 
Discussion: This is the first trial of community-based rehabilitation for schizophrenia and will determine, as a proof of 
concept, the added value of community-based rehabilitation compared to facility-based care alone in a low-income 
country with scarce mental health resources. 
Trial registration: Clinical Trials.gov Identifier NCT02160249. Registered on 3 June 2014. 
Keywords: Schizophrenia, Psychosis, Community-based rehabilitation, Disability, Cluster randomised trial, Ethiopia, 
Low-income country 
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Schizophrenia can be a severe, chronic and disabling 
condition, which places a high social and economic bur- 
den on individuals [1], families [2] and society. The major- 
ity of people with schizophrenia in sub-Saharan Africa do 
not have access to adequate care [3]. Over half of the 
people with schizophrenia in Ethiopia experience continu- 
ous or episodic illness over a 10-year period [4], where the 
treatment gap is estimated to be 90 % [5, 6]. Mortality is 
high; the standardised mortality ratio for people with 
schizophrenia in Ethiopia is twice that of the general 
population [7]. People with schizophrenia are also likely to 
experience stigma and discrimination [8, 9] and human 
rights violations [10]. 
According to global consensus, supported by scientific 
review of the evidence and the experience of mental 
health system experts, a comprehensive mental health sys- 
tem includes both community- and hospital-based com- 
ponents of care [11, 12] and should incorporate both 
medication and psychosocial interventions [13, 14]. Rela- 
tively low-intensity psychosocial community-based pro- 
grammes, which are likely to be most feasible, have been 
shown to be effective in low- and middle-income country 
(LMIC) settings [15–17]. To date such programmes have 
typically involved four groups: the patient, family mem- 
bers, a community-based non-specialist key worker and a 
psychiatrist [14]. In particular, the World Health Organi- 
sation’s (WHO’s) mental health Gap Action Programme 
(mhGAP) recommends community-based rehabilitation 
(CBR) as an adjunct to medication for schizophrenia [18]. 
CBR is a general approach with the aim to improve the 
quality of life and social inclusion of people with disabil- 
ities [19] and is typically delivered by trained lay workers 
from the local community. Key pillars of a CBR 
programme include interventions that promote health, 
education, livelihood, and social life. In addition there is a 
cross-cutting emphasis on empowerment, such as support- 
ing people with disabilities to make their own decisions. 
CBR is put into practice through the joint endeavours of 
people with disabilities, their caregivers, community mem- 
bers and relevant governmental and non-governmental 
services, including health services [20]. 
CBR programmes have traditionally focussed on people 
with physical disabilities. There is increasing recognition 
that people with mental disorders may also receive benefit 
from a service model that integrates mental health and 
economic development [21, 22]. CBR may impact on clin- 
ical and disability outcomes in people with schizophrenia 
by improving understanding of the illness, increasing ad- 
herence to antipsychotic medication, reducing stigma and 
improving social functioning. 
Globally there are a few examples of CBR programmes 
for people with mental disorders [17, 23–30]. A systematic 
review found that CBR may improve clinical outcomes 
 
and functioning for schizophrenia, dementia and intellec- 
tual disabilities in LMICs [20]. However, no randomised 
controlled trials (RCTs) of CBR for schizophrenia that in- 
volved community mobilisation (defined as ‘a strategy 
which aims to engage community members and empower 
them for change or action’ [19]), or focussed primarily on 
any CBR pillar other than health, were included [20]. Fur- 
thermore, there were no studies set in countries defined 
by the World Bank as being low-income [20]. The more 
recent COmmunity care for People with Schizophrenia in 
India (COPSI) trial [31], a study from India (a middle- 
income country), found that collaborative community care 
modestly improved disability and symptoms in people 
with schizophrenia [17]. The greatest effects were seen in 
rural areas with fewer formal mental health resources. 
Whilst influenced by CBR, the intervention did not in- 
clude community mobilisation, and participants had ac- 
cess to psychiatrists as a key component of care. 
To our knowledge there has been no previous rando- 
mised trial investigating the impact of a comprehensive 
CBR programme,  including  both  home-based  care  and 
a structured community mobilisation element, on out- 
comes in people with schizophrenia. Furthermore, the 
effectiveness of CBR for schizophrenia has not previ- 
ously been examined in a low-income setting, such as 
Ethiopia, which has minimal formal mental health re- 
sources. Currently, most people with schizophrenia in 
rural Ethiopia will never have access to a psychiatrist, 
psychiatric nurse or other mental health professional. 
However, mental health care is being scaled up in 
Ethiopia by training general health workers, largely in 
primary care, to deliver care for people with mental dis- 
orders. This process illustrates the Ethiopian Ministry of 
Health’s efforts to improve access to mental health care 
[32]. 
Extensive formative research using a variety of 
methods nested within a Theory of Change  framework 
has enabled the design of a culturally and contextually 
appropriate CBR intervention for people with schizo- 
phrenia that is acceptable and feasible to service  users 
and providers in rural Ethiopia [33, 34]. The CBR inter- 
vention, which includes home-based care, community 
mobilisation and family support groups, has been 
piloted. This paper presents the protocol for the Re- 
habilitation Intervention for  people  with  Schizophrenia 
in Ethiopia (RISE) project, a cluster randomised trial, 





To evaluate the effectiveness of CBR as an adjunct to 
facility-based care (FBC), compared to FBC alone, in re- 
ducing  disability  related  to schizophrenia  at  12 months, 
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measured by the WHO Disability Assessment Schedule 
(WHODAS) version 2.0 in patients with evidence  of 
poor response or lack of engagement in care over the 




1. To evaluate the effectiveness of CBR plus FBC 
compared to FBC alone in reducing clinical 
symptoms, reducing relapse, increasing medication 
adherence, improving economic activity, reducing 
physical restraint, reducing discrimination, and 
improving nutritional status in people with 
schizophrenia. 
2. To evaluate the effectiveness of CBR plus FBC 
compared to FBC alone in reducing family burden, 
stigma and depression, and improving economic 
activity in caregivers of people with schizophrenia 
3. To explore the acceptability and feasibility of CBR 
from the perspective of (1) those receiving the 
treatment, (2) their families, and (3) those delivering 
the treatment. 
 
4. To determine the cost-effectiveness of CBR plus 
FBC compared to FBC alone. 
5. To investigate the process through which CBR 
achieves its impact. 
 
Primary hypothesis 
People with schizophrenia who receive CBR in addition 
to FBC will experience greater reductions in disability 
compared to those who receive only FBC, to the order     
of 20 % absolute difference in WHODAS 2.0 score be- 




The design is a cluster randomised controlled trial with 
sub-district (pre-defined  administrative  unit  consisting 
of several villages together) as the unit of randomisation. 
The study flow chart is presented in Fig. 1. From 58 sub-
districts in the study district, four sub-districts were sites 
for the pilot and the remaining 54 sub-districts will be 
included for the actual trial; 27 will be randomly allo- 
cated  to  the  intervention  arm  (FBC  plus  CBR)  and 27 
 
 
Fig. 1 RISE flow chart 
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randomly allocated to the control arm (FBC alone). In 
total, 182 participant dyads (patients and their caregivers) 
will be recruited. On average there will be 3.4 participant 
dyads per sub-district. 
Cluster randomisation is the chosen method of ran- 
domisation because first, CBR includes community-level 
elements and family support groups, based on sub- 
districts, so individual randomisation is not possible; sec- 
ond, it is logistically more convenient to  concentrate 
CBR workload in fewer sub-districts; and third there is 
increased acceptability if all participants in a sub-district 
are allocated to either intervention or control arms. This 
paper follows the Standard Protocol Items: Recommen- 
dations for Interventional Trials (SPIRIT) recommenda- 
tions for trial protocols (see Additional file  1). 
 
Setting 
The trial will take place in Sodo district, Gurage Zone, 
Southern Nations, Nationalities and Populations Region 
(SNNPR) in Ethiopia. The administrative town of Sodo, 
Bui, lies 100 km from Addis Ababa. Sodo district has a 
population of 170,000 persons in 58 sub-districts: four 
urban and 54 rural. Most people live in one-room mud 
and straw houses and work as  subsistence farmers. 
About 45% of the population are literate and the major- 
ity are Orthodox Christian by  religion. 
There is a psychiatric nurse-led outpatient clinic at the 
general hospital in Bui. There is a similar unit at Butajira 
hospital, which is 30 km away from Bui in the neigh- 
bouring district. Primary health care is delivered through 
eight primary health care centres staffed by health offi- 
cers and general nurses. Each health centre oversees 
between four and 11 health posts, staffed by two health 
extension workers (HEWs). Each health post covers a 
sub-district, with a population of 2800–5000 people. 
Health care costs are largely out-of-pocket with a free 
waiver available for the poorest; in practice a tiny minor- 
ity of the population are likely to be in receipt of this 
waiver. 
 
Context of the study 
The RISE trial is nested in PRIME (PRogramme for Im- 
proving Mental healthcarE). PRIME is a multicountry re- 
search consortium that aims to generate evidence on the 
implementation and scaling up of packages of care for 
priority mental disorders in primary health care  in 
LMICs [35, 36]. As part of the PRIME project, a com- 
prehensive mental health care plan was developed for 
Ethiopia [37–39] and, from December 2014, facility- 
based care for schizophrenia was embedded in primary 
health care centres in Sodo district. Health officers and 
nurses were trained in the detection and treatment of 
schizophrenia, including the prescription of anti- 
psychotic   medication   and   psychoeducation.    Training 
 
followed the WHO’s mhGAP and evidence-based guide- 
lines [18, 40], adapted for the Ethiopian context. PRIME 
identified people with schizophrenia in Sodo using the 
Butajira key informant method [41] and, from December 
2014, began following up those invited to access FBC in   
a 12-month treatment cohort. A subsample of the  
PRIME cohort participants will be recruited to the RISE 
trial at the PRIME 6-month data collection. The ration- 
ale for recruiting into the trial  after  participants  have  
had 6 months access to FBC is that if this intervention 
were scaled up in a resource-poor setting such as 
Ethiopia, it would only be made available for those with 




FBC will be available to all participants in the RISE trial. 
The frequency of contact with FBC will be determined  
by clinical need. Within formal health care, FBC is a 
three-tier system, but the majority of care will be deliv- 
ered at tier 1, which is primary care (Table   1). 
 
Community-based  rehabilitation 
Intervention  development 
The CBR intervention was constructed through in-depth 
intervention development work as described in detail 
elsewhere [34, 42]. The work included a literature  re- 
view, situational analysis [43, 44], an intervention devel- 
opment workshop, participatory meetings, qualitative 
interviews with a range of stakeholders, including people 
with schizophrenia, their caregivers, psychiatrists and 
community leaders, and collaboration with an existing 
CBR project, RAPID (Rehabilitation And Prevention Ini- 
tiative against Disabilities). RAPID is an Ethiopian CBR 
project for children with  disabilities. 
 
CBR worker recruitment and training 
Eleven CBR workers were recruited according to the cri- 
teria: (1) completed tenth grade education (secondary 
school), (2) resident in Sodo district, and (3) interest in 
community work. Training lasted for 5 weeks and com- 
prised an equal split of classroom teaching and  field 
work, including home visits to people with schizophrenia 
and on-the-job training at RAPID. Psychiatrists and CBR 
trainers from RAPID delivered the training. Competency 
was assessed using role-plays and patient vignettes. 
 
Pilot 
A 12-month pilot was conducted. The pilot included ten 
people with schizophrenia and their families living  in  
four sub-districts not involved in the main  trial.  The 
aims of the pilot were to determine the acceptability and 
feasibility of the CBR intervention and to refine the 
intervention    and    trial    design    as    needed.      Major 
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Table 1 Facility-based care three-tier system for the treatment of mental illness 
Location Staff Tasks Referral 
Tier 1: primary care 











Tier 2: general secondary care 
Health officers 
and nurses 
• Prescribe antipsychotic medication (oral haloperidol 
or chlorpromazine) and monitor response 
• Manage side-effects 
• Monitor suicide risk 
• Review physical health 
• Screen for substance misuse 
• Provide basic psychoeducation 
(information about schizophrenia) 
• Provide regular follow-up 
• Refer to tier 2 in the following scenarios: 
o Active suicidal intent 
o Inadequate oral intake of fluid or food 
o Risk of violence to others and/or risk 
of serious self-neglect 
o Persistently non-adherent to  medication 
o Acutely disturbed and not 
manageable at home 
o Pregnancy/breastfeeding 
o Medical complications 
o Unmanageable side-effects 
Psychiatric outpatient clinic at 
Butajira Hospital 
 
Tier 3: specialist care 
Ammanuel Psychiatric 
Hospital, Addis Ababa 
Psychiatric nurse  • Specialist review 




Psychiatrist • Specialist review 
• Inpatient admission where  required 
• Refer to tier 3 when inpatient care is 
required 
• Refer back to tier 1 for follow-up 
 
 





adjustments to the intervention and trial design were 
made prior to the trial starting. Minor adjustments may 
be made to the latter components of the CBR interven- 
tion on the basis of pilot findings. 
 
Trial CBR delivery 
One or two CBR workers will be attached to each health 
centre and each will cover two or three  sub-districts.  
Each CBR worker will have approximately eight people 
with schizophrenia under their care. The  delivery  of 
CBR for schizophrenia will be the only task for the CBR 
workers. CBR delivery will commence immediately after 
recruitment   into   the   trial   and   will   continue   for    
12 months. The CBR visits will take place at the partici- 
pants’ home and last 30–90 minutes. The intervention is 
delivered in three phases (Table  2). In phase 1, lasting 2 
to 3 months, there are weekly home visits and the focus   
is on engagement with the family and addressing core 
needs through compulsory modules such as ‘Under- 
standing Schizophrenia’. In phase 2, lasting approxi- 
mately 5 to 6 months, home visits are every 2 weeks and 
address the specific needs of the individual through op- 
tional modules such as ‘Getting Back to Work’. In phase 
3, lasting approximately 4 months, the emphasis is on 
preventing relapse as well as maintaining the progress 
made towards addressing specific needs. CBR workers 
conduct community mobilisation work and may run 
family support groups alongside the home visits. The de- 
tailed content of CBR at each phase of the intervention   
is described in Table 1. Flexibility will be encouraged ac- 
cording to the needs of the individual participant  and  
their caregiver. CBR delivery will be guided by a manual 
that outlines steps for the delivery of each module and 
community   engagement   task,   procedures   for  referral 
and how to deal with difficult situations, for example, 
suicidal ideation. Two supervisors will maintain an over- 
view of the frequency, content and quality of the home 
visits by CBR workers for each participant. Supervision 
will include monthly unannounced observed sessions, 
with individual face-to-face supervision and group 
supervision every 2 to 4 weeks. Unannounced visits will 
take place only with the prior permission of participants. 
The trial coordinator will attend group supervision 
monthly and conduct a paper-based review of all cases 
every 2 weeks with each supervisor. The coordinator will 
ensure the on-going fidelity of CBR delivery and guide 
top-up training sessions for CBR workers where 
required. 
 
Selection and randomisation of clusters 
We will aim to include all 54 sub-districts in Sodo dis- 
trict (after excluding the four pilot sub-districts). The 
randomisation of sub-districts into CBR plus FBC and 
FBC arms will be stratified by health centre. A minimisa- 
tion algorithm [45] will be employed to ensure balance 
for (1) urban/rural location, (2) number of potential 
participants (i.e. cases of schizophrenia in the PRIME 
cohort) in the sub-district, and (3) mean WHODAS 2.0 
score in the sub-district at PRIME cohort baseline. All 
these factors may potentially impact on the primary out- 
come. PRIME cohort baseline WHODAS 2.0 scores will 
only provide an estimate of the disability level of poten- 
tial participants as this data will not be available for the 
entire pool of trial participants and will not represent 
disability levels at the time of recruitment. The alloca- 
tion sequence will be generated randomly from the set     
of optimal sequences [46]. An independent  statistician 
will generate the allocation list for sub-districts. This    list 
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Table 2 RISE community-based rehabilitation (CBR) intervention  outline 
Phase Months Visits  
Assessment and family 
CBR activities 
Community  mobilisation 
 
Family-level interventions 	 	 	 engagement 	 	
1: Intensive ~1–3 Weekly • Developing therapeutic • Resource mapping for sub-district, e.g. Core modules: 
engagement 	 	 alliance with family 
• Needs assessment 
churches, schools, edir groups (traditional 
burial association), Women’s Association, 
• Understanding schizophrenia 
• Improving access to health care 	 • Risk assessment literacy groups, religious groups and • Dealing with human rights issues 
• Goal setting for phase 1 traditional healers • Preparing for a crisis 





2: Stabilisation ~4–8 Fortnightly  • Update needs assessment 
• Risk assessment 
• Goal setting for phase 2 













3: Maintenance  ~9–12   Monthly • Update needs 
assessment 
• Risk assessment 
• Goal setting for phase 3 
• Update rehabilitation 
plan 
• Prepare for termination 
• Continuing care 
assessment 
targeting health extension worker, 
community leaders and traditional  healers 
• Awareness raising meeting/s with general 
public in sub-district 
• Facilitate access to relevant community 
resources 














• Consolidate access to community 
resources 







• Supporting individuals to take 
medication 
• Improving the family environment 
(coping skills, marital problems) 
• Improving day-to-day functioning 
• Taking part in community life 
• Getting back to work 
• Dealing with distressing symptoms 
• Dealing with stigma and discrimination 
• Improving physical health 
• Dealing with stress and anger 
• Improving literacy 
• Family support groups 
• Taking control of your illness (relapse 
prevention  and management) 
Core module: 
• Taking control of your illness (relapse 
prevention and management) if not 
completed in phase 2Optional 
modules 




is will be kept securely by the trial coordinator and uti- 
lised to determine allocation status of new   recruits. 
 
Participant inclusion criteria 
There are no specific exclusion  criteria.  Participants 
must meet all of the following criteria to be included: (1) 
be a participant in the PRIME cohort study or not en- 
gaged in FBC but resident in Sodo district, (2) have been 
resident in the sub-district for more than 6 months and 
have no immediate plans to leave the sub-district,  (3) 
have a primary caregiver who is willing to participate in 
the study, (4) be aged 18 years older, (5) have a diagnosis 
of schizophrenia spectrum disorder (schizophrenia, schi- 
zoaffective disorder or schizophreniform disorder) using 
Diagnostic and Statistical Manual of Mental Disorders, 
version four (DSM-IV) [47] criteria, and (6) have evi- 
dence of enduring or disabling illness demonstrated by 
one or more of the following: (a) Brief Psychiatric Rating 
Scale – Expanded version (BPRS-E) score ≥52 (equiva- 
lent to at least ‘moderately ill’ on the Clinical Global Im- 
pression  (CGI)  scale)  [48],  (b)  36-item  WHODAS  2.0 
score ≥35, (c) have continuous illness over the   preceding 
6 months, as assessed using the Life Chart Schedule 
(LCS), (4) be symptomatic in 3 out of the last 6 months, 
as assessed using the LIFE chart, or  (e)  have  a  CGI 
score ≥3 (at least ‘mildly ill’). The final criterion allows  
us to include the group expected to benefit  the  most  
from CBR and also reflects the threshold at which CBR 





PRIME aimed to detect all people with schizophrenia in 
Sodo by training key informants (HEWs and community 
leaders) to identify possible cases. This method was suc- 
cessful at identifying people with psychosis in previous 
Ethiopian studies, including in the neighbouring district 
[41, 49, 50]. Possible cases of schizophrenia were invited 
to their health centre for diagnosis and treatment. If they 
attended, a psychiatric nurse conducted a diagnostic 
interview  using  the  OPCRIT  (Operational  Criteria   for 
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Research), an operational criteria checklist for psychotic 
and affective illness [51, 52]. The OPCRIT facilitated the 
nurse to determine if participants had a DSM-IV diagno- 
sis. Substantial inter-rater reliability and convergent valid- 
ity of the OPCRIT has been demonstrated in  other 
settings [53] and there is good experience of using 
OPCRIT in a clinical trial of schizophrenia in the neigh- 
bouring district [54]. All confirmed cases of schizophrenia 
spectrum disorders were offered FBC and, where they 
consented, were recruited into the PRIME cohort. Prior to 
RISE recruitment a psychiatrist conducted an additional 
paper-based diagnosis review of all PRIME cohort partici- 
pants using the clinical instruments completed at baseline, 
including the OPCRIT. Where the  psychiatrist  deemed 
the diagnosis unclear, a repeat clinical assessment by the 
psychiatric nurse will be completed prior to RISE 
recruitment. 
 
Participant  recruitment 
Participants for the RISE trial will be primarily recruited 
from people who were identified and received a diagno- 
sis of a  schizophrenia  spectrum disorder at the baseline 
of the PRIME cohort and their caregivers, and were liv- 
ing in the sub-districts selected  to  participate  in  the 
RISE trial. However, we will recruit from up to  four  
pools of potential participants, known as recruitment 
levels. 
Level 1 recruitment comprises recruitment from the 
PRIME cohort at the 6-month data collection interview, 
which takes place at the health centre. Level 2 recruit- 
ment comprises recruitment from PRIME cohort drop- 
outs, i.e. those who do not attend the PRIME 6-month 
data collection. Level 3 recruitment comprises recruit- 
ment from those who were identified by key informants 
but have never attended FBC. This group had some 
baseline data collected through a home visit by PRIME 
as part of a non-engagement study. Level 4 recruitment 
comprises recruitment from those individuals who were 
identified by key informants as potential cases with 
schizophrenia after the recruitment for the PRIME co- 
hort had ended. Level 1 recruitment will take place at 
consecutive pairs of health centre catchment areas, de- 
termined by the PRIME data collection schedule. For 
levels 2, 3 and 4 recruitment, all sub-districts will be 
covered equally to avoid unequal recruitment by treat- 
ment arm. RISE recruitment will take place either at the 
health centre at PRIME data collection or at a follow-up 
visit at the participant’s home. 
The aim of incorporating non-PRIME cohort partici- 
pants is that these non-engagers in care are  likely  to  
have more complex needs, and be  more  symptomatic  
and disabled. They are, therefore,  the  individuals  who 
are likely to receive the most benefit from CBR. Some of 
these individuals will not be accessing care because   they 
 
are currently well, and will be excluded from the trial 
using the standard recruitment criteria. 
Within each CBR worker area, the transition from one 
recruitment level to the next will continue until approxi- 
mately eight participants have been recruited for each 
CBR worker. The aim is to ensure CBR workers have 
equal workloads, to ensure CBR delivery is as uniform   
as possible. If it is not possible to recruit eight partici- 
pants in any particular CBR worker area (after exhaust- 
ing all recruitment levels), recruitment will continue at 
other CBR worker areas whilst aiming to keep the num- 
ber of participants per CBR worker as equal as possible. 
Recruitment will proceed to the next recruitment level/s 
until a maximum of 12 participants per CBR worker are 
recruited. This is because the maximum feasible workload 
for CBR workers is expected to be 12 participants. There 
may be slight adjustments to the number of participants 
recruited per CBR worker depending on drop-out of CBR 
workers or other unforeseen factors. 
 
Recruitment procedures 
The recruitment procedures for each of these groups 
will be detailed in dedicated Standard Operating Proce- 
dures (SOPs). Potential participants in the PRIME co- 
hort will have their eligibility for the RISE trial checked 
by the trial coordinator or trial nurse using PRIME 6- 
month data (i.e. WHODAS 2.0, BPRS-E, CGI, LIFE 
chart and LCS). Eligible participants will be invited to 
join the RISE trial by a trial nurse. They will be given in- 
formation about the trial in a way appropriate to the 
participants’ literacy level, which may include verbal in- 
formation. The trial nurse will then conduct the consent 
procedures. 
Participants not in the PRIME cohort will have an initial 
consent taken, before data is collected on the eligibility in- 
struments, including the diagnostic interview. Those who 
are eligible will then be consented to take part in the RISE 
trial. Those who consent (or, for those without decision- 
making capacity, whose caregiver consents on their be- 
half) will complete the full RISE baseline data collection. 
 
Allocation 
The randomisation of sub-districts to intervention and 
control arms will take place before recruitment. The ra- 
tionale is that it is necessary to commence delivery of    
the CBR intervention  immediately  after  recruitment. 
The trial coordinator will keep the sub-district allocation 
list secure on a password-protected document. To re-  
duce selection bias, the potential participant will not be 
informed of the allocation of their sub-district until after 
they have consented to participate and all baseline data 
collection is complete. The trial nurse will also be blind   
to the allocation. The trial coordinator will assign a 
unique  trial  identifier  (ID)  to  each  new  participant and 
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Table 3 Summary of outcome measures 
Outcome Instrument 
 
Psychiatric nurse-administered interview with  patient 
Symptom severity Brief Psychiatric Rating Scale – Expanded version (BPRS- E) [62]. A 24-item instrument 
focussing on psychotic symptoms, but also covering somatic concerns, anxiety, 
depression and mania. Individual BPRS-E items and total score are sensitive to change 
in persons with persistent schizophrenia [63]. The scale has been previously used in 
Ethiopia [64] and has recently been shown to have good inter-rater reliability (>0.8 
comparing psychiatric nurses and psychiatrists) in this setting (personal communication, 
Dr Charlotte Hanlon) [65]. As the scale is clinician-rated this allows for sociocultural 
sensitivity. Inter-rater and test-retest reliability as well as internal consistency are also 
high in high-income settings [66] 
Clinical impression Clinical Global Impression (CGI). A widely used assessment tool, comprising three 
scales, to determine overall illness severity and efficacy of intervention [67] 
Relapse Life Chart Schedule (LCS) including course type and relapses [68]. 
Longitudinal Interval Follow-up Evaluation: DSM-IV version (LIFE). A semi-structured 
interview to determine the subject’s psychiatric course since the last interview [69]. 
Satisfactory validation has been conducted in Ethiopia and the reliability data is 
currently being analysed. Any necessary adjustments will be made on the basis of 
the inter-rater reliability assessments (personal communication, Dr Girmay Medhin) 
Lay data collector-administered interview with the patient 
Disability Patient-reported 36-item WHODAS (Disability Assessment Schedule) 2.0 [55]. 
A validated indigenous functioning scale, specific to the Ethiopian context [70] 
Economic activity Measure covering current employment, subsistence farming work,  income, and 
hunger due to lack of resources 
Discrimination Section 1 of the Discrimination and Stigma Scale-12 (DISC-12) [71] 
Medication adherence Adapted Morisky Medication Adherence Scale (MMAS) [72]. This scale has previously 
been utilised for antipsychotic medication adherence [31, 73]. Good construct 
validity has been demonstrated in Ethiopia (personal communication, Dr Charlotte 
Hanlon) [65]). 
A 5-point nominal scale measuring frequency of adherence [31] 
Health service use and costs including engagement with 
FBC for schizophrenia and physical health conditions 
 
 
Access to community interventions (including CBR 
components) 
An adapted version of The Client Service Receipt Inventory (CSRI) will enquire 
systematically about the costs (direct and indirect) of help-seeking from biomedical, 
traditional and religious healers [74, 75]. The CSRI has been translated into Amharic 
and found to be acceptable and feasible [76] 
Including person administering the component, and satisfaction 
Physical restraint In the preceding 1 and 6 months. Includes assessment of duration, perpetrator, 
setting and reason for restraint 
Nutritional status Measurement of weight (kg) and height (m) will be carried out [77] and body mass 
index (weight in kg/(height in m)2) calculated 
Depression The Patient Health Questionnaire- 9 (PHQ-9). A 9-item scale which scores each of 
the 9 DSM-IV criteria for depressive disorders as ‘0’ (not at all) to ‘3’ (nearly every 
day) [78]. Shown to be valid in the Ethiopian setting [79] 
Alcohol use disorder The AUDIT (Alcohol Use Disorders Identification Test) is a ten-item tool to detect 
hazardous drinking [80] 
Social support Oslo-3 Social Support Scale [81] 
Serious adverse events Occurrence of serious adverse events (for example, suicide attempt and 
hospitalisation for medical emergency) in the last 6 months 
Lay data collector interview with the primary caregiver 
Patient disability The 36-item WHODAS 2.0 proxy version will assess functional impairment from the 
caregiver’s perspective [82, 83] 
Economic activity of caregiver Employment, subsistence farming work, income, and hunger due to lack of 
resources 
Caregiver burden The Burden Section of the WHO ‘Family Interview Schedule’. This scale, covering 
financial strain and work difficulties has been previously used in Ethiopia for persons 
with schizophrenia [2]. 
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A scale developed for PRIME will quantify the time burden of caring for their 
relative with schizophrenia, the type of work that was stopped or reduced and the 
amount of money lost. The Involvement Engagement Questionnaire (IEQ) will be 
used as an additional measure to assess caregiver burden. 
Caregiver depression PHQ-9 [78, 79] 
Stigma Section of the WHO ‘Family Interview Schedule’; previously used in Ethiopia [8] 
Patient medication adherence The 5-point nominal scale developed for the COPSI study will be used [31] 
CBR community-based rehabilitation, DSM-IV Diagnostic and Statistical Manual of Mental disorders, version four, FBC facility-based care 
 
 
will determine the allocation of  all  new  recruits  using 
the secure allocation list. Recruitment and  participant 
flow will be closely monitored by the trial coordinator 




All outcomes are individual-level and will be assessed at 
6 and 12 months (Table 3). Baseline RISE data will be 
extracted from 6-month PRIME cohort data and  6- 
month RISE data will be extracted from  12-month 
PRIME cohort data. Twelve-month RISE data will be 
collected independently of the PRIME  cohort.  Trained 
lay data collectors will collect all data except for symp- 
tom severity, clinical course, overall clinical impression 
of illness severity and improvement, and medication, for 
which a trained psychiatric nurse will be used. Patient 
outcomes will be collected with the caregiver present ac- 
cording to participant preference and when the patient 
does not have the capacity to answer questions inde- 
pendently. Data will be collected directly from the pa- 
tient where possible (except for caregiver-reported 
outcomes). Items will be recorded as missing in the sce- 
nario that the caregiver is not present due to patient re- 
fusal, and the patient is unable or unwilling to respond. 
Quality will be assured through systematic observations   
of data collection by a research assistant (for lay data 
collectors) or psychiatrist (for psychiatric nurse data col- 
lectors), and by verification of all patient record forms. 
Regular meetings will be held to provide  feedback  to 
data collectors. 
In order to reduce information bias data collectors will 
be masked to sub-district allocation; participants will be 
requested not to divulge treatment allocation to data 
collectors; participants from different  sub-districts  will  
be allocated to each data collector; identical methods for 
follow-up will be employed in each arm; and those in- 
volved in data analysis will be masked to sub-district 
allocation. 
Loss to follow-up will be minimised by reminding par- 
ticipants to attend the interview shortly before they are 
due, either by telephone or by a home visit. Participants 
who do not attend will receive a home visit to ask them 
 
to attend at an alternative time. Data collection will take 
place at  the health centre except for participants who  
do not attend after three invitations. These participants 
will receive a home visit for data collection. Partici- 
pants will receive a modest fee for transport and time 
compensation. 
The primary outcome is proxy report of patient dis- 
ability which will be measured with the 36-item WHO 
DAS (Disability Assessment Schedule) 2.0 [55], through 
interviewing the caregiver. WHODAS 2.0 was developed 
as single generic instrument for assessing health status 
and disability relating to a range of health conditions 
across cultures and settings. It covers understanding and 
communication, getting around, self-care, getting along 
with people, life activities and participation in society. 
Sociocultural adaptation and validation (convergent val- 
idity, construct validity and responsiveness to change) of 
the WHODAS 2.0 in persons with schizophrenia  has 
been completed in Ethiopia (personal communication, 
Kassahun Habtamu). Issues arising during the adaptation 
included items not having  obvious  direct translations  
and representing uncommon experiences in the rural 
Ethiopian setting (for example, ‘staying by yourself for a 
few days’). These issues were largely resolved through it- 
erative adjustments to the translation following piloting. 
The proxy WHODAS 2.0 interview is designed to be an- 
swered by a friend, relative or carer. The rationale for 
using the proxy version for the primary outcome is that 
this may give a more valid picture of disability level. A 
separate study in the neighbouring district found that 
whilst scores from patient- and proxy-reported versions 
are moderately correlated, there is a difference, with the 
caregiver scores tending to be higher (greater disability) 
(personal communication, Kassahun Habtamu). Patients 
may not have enough insight to answer accurately and, 
therefore, underreport disability. They may also be too 
unwell to answer all questions, increasing the amount of 
missing data. Table 3 lists the  secondary  outcomes, 
which include patient-reported WHODAS 2.0, symptom 
severity, relapse, medication adherence, economic activ- 
ity in the patient and caregiver, discrimination, health 
service use and costs, physical restraint, nutritional sta- 
tus, caregiver burden, caregiver depression and   caregiver 
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stigma. All instruments have been adapted for use in 
Ethiopia; further details on validation and reliability are 




Process data will be  compiled using  a range  of sources 
to determine the quality and intensity of intervention 
delivery. These include (1) CBR worker ‘sub-district’ 
logbooks, including type and number of community en- 
gagement tasks completed, (2) CBR worker ‘participant’ 
logbooks including home visit forms (modules under- 
taken,  duration  and  travel  time)  and  assessment forms, 
(3) monthly observation of CBR visits by supervisor and 
completion of the ENACT (Enhancing Assessment of 
Common Therapeutic factors) rating scale [56] adapted 
and validated for the Ethiopian context. The adapted 
ENACT assesses communication skills, engagement with 
the individual, family and community, assessment of 
medication adherence, physical health,  substance  use 
and suicide risk assessment, (4) observation of  CBR 
home visits by an external clinician (psychiatric nurse or 
psychiatrist) to complete the ENACT, providing an inde- 
pendent assessment of CBR worker skills, (5) CBR 
worker competency assessment by supervisor (rating of    
1 to 3 given for each of 47 CBR competencies, e.g. ability 
to conduct community awareness raising meeting), (6) 
CBR worker self-assessed competency form, (7) super- 
visor logbook including number of supervision sessions 
attended, (8) health centre records to determine fre- 
quency of contact with participant, and (9) participant- 
reported structured assessment of the extent to which  




In-depth interviews (IDIs) will be conducted at baseline 
and 12 months with a sub-sample of patients and care- 
givers to gather information on the impact of CBR and 
other factors on the experience of illness and recovery. 
Around eight to ten participant dyads from each treat- 
ment arm will be included depending on when theoret- 
ical saturation is reached. After gaining separate 
informed consent, interviews will be audio-taped, tran- 
scribed in Amharic and then  translated  into  English 
prior to conducting a thematic analysis. IDIs will be con- 
ducted with four to eight community leaders to under- 
stand their role in CBR and their perception of its 
potential impact. IDIs and FGDs will be conducted with 
CBR workers and supervisors to understand their ex- 
perience of delivering CBR and its perceived impact on 
participants. One or two focus groups will also be held 
with health centre nurses to understand their experience   
of working with CBR workers. 
 
Power calculation 
We estimate that 182 participant dyads (mean 3.4 partic- 
ipants/sub-district) will be available for recruitment. As- 
suming that there is 23 % attrition, the final sample size 
for analysis will be 140 participant dyads in 54 sub- 
districts (mean 2.6 participants/sub-district). This  sam- 
ple size will allow us to detect a 20 % absolute difference 
in WHODAS 2.0 scores  between  treatment  arms  with 
85 % power and 5 % significance, assuming a k (coeffi- 
cient of variation) of 0.14 and a within-cluster standard 
deviation (SD) of 16. The value of k was extracted from 
symptom severity data by sub-district from an RCT in 
Butajira evaluating trimethoprim as an adjuvant treat- 
ment for schizophrenia (k = 0.11) [57]. A more conserva- 
tive estimate of k has been used to account for the 
potential therapist effect; each CBR worker will cover 
around three sub-districts and CBR intensity and quality 
may differ by CBR worker. The mean WHODAS 2.0 in 
intervention and control arms and  within-cluster  SD 
were derived from an Indian study of people with 
schizophrenia [58]. 
The estimate of 182 participant dyads available for re- 
cruitment was arrived at using (1) the total adult population 
of Sodo district, (2) the local prevalence of schizophrenia 
(0.05 %) [59], (3) an estimate that 60 % of cases will be de- 
tected and agree to participate in the PRIME cohort, (4) 
an assumption that 70 % of cases will be eligible for RISE, 
based rates of continuous illness found in a previous study 
in the neighbouring district of Butajira [5], and (5) an as- 
sumption that approximately 80 % of eligible cases will 
agree to participate, based on previous recruitment rates   




All data collection and management will follow Good 
Clinical Practice (GCP) guidelines and SOPs. Each par- 
ticipant has a unique ID that will enable all data  re-  
ported for each participant to be identified. Blinding will 
be maintained during data collection, entry,  processing 
and primary data analysis. Data is collected on paper 
Patient Report Forms (PRF) and double entered onto 
electronic Case Report Forms on EpiData Entry Client 
(2.0.7.22). Data will be managed using EpiData Data 
Manager (2.0.8.56). 
All databases will be password-protected and only access- 
ible to authorised personnel. Data cleaning based on fre- 
quency distributions and logic checks will follow standard 
procedures with reference to source documents as required. 
The data system is designed to ensure that all data changes 
are documented and that there is  no undocumented  dele- 
tion of entered data, i.e. an audit trail will be in place. Sys- 
tematic checks will be carried out to ensure that the audit  
trail   is   functioning   correctly.   Data   and   all appropriate 
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documentation will be stored for a minimum of 5 years 




Data analysis will take place using Stata, version 13. The 
primary outcome analysis will be masked until the ana- 
lysis is finalised and approved by all investigators. 
Adequate CBR will be defined as having received a mini- 
mum of ten home visits by a CBR worker. We will not 
define adequate treatment for the FBC arm a priori. 
Sociodemographic and clinical characteristics (including 
WHODAS 2.0 score) of eligible PRIME cohort partici- 
pants who did and did not consent to RISE will be com- 
pared using chi-square tests and t tests. Loss-to-follow-up 
will be compared by treatment arm at 6 and 12 months to 
assess bias due to loss to follow-up. Of those who en- 
rolled, descriptive summaries of sociodemographic and 
clinical characteristics, presented by treatment arm, will 
be produced for baseline data. CBR worker characteristics 
such as age, gender, education level and post-training 
competency will be described. 
Endpoint data will be  analysed  under  intention-to- 
treat assumptions. An individual-level analysis will be 
conducted using a multilevel, mixed-effects regression 
model to compare the WHODAS 2.0 score between 
treatment arms, accounting for clustering at sub-district 
and CBR worker levels. The WHODAS 2.0 distribution 
will determine the model used. If zero-inflation is de- 
tected, a zero-inflated negative binomial model will be 
considered [60]. Adjustment will be made for baseline 
WHODAS 2.0 score and covariates unbalanced at base- 
line. Logistic regression will be used to assess which 
baseline variables are associated with missing outcome 
data. Baseline variables that predict  missing  outcome 
will be included in the regression models as fixed covari- 
ates to meet the assumption that outcome data is miss-   
ing at random. Multiple  imputation  methods  will  then 
be used for participants with missing outcome   data. 
Sensitivity analyses will include a complete case ana- 
lysis and a complier average causal effect (CACE) ana- 
lysis [61]. We will also assess whether there is a dose- 
response relationship between degree of adherence to 
CBR (i.e. number of sessions) and the primary outcome. 
A further analysis will be undertaken to  understand 
which the active components of CBR are. Process data    
on which CBR components were received, and in what 
quantity, will be utilised. Potential correlations between 
different components will be taken into   account. 
Exploratory sub-group analyses by baseline symptom 
severity and antipsychotic medication  adherence  will 
be completed, although the  study will not be  powered  
to investigate such differential effects. A longitudinal 
analysis   will   be   conducted   using   a random-effects 
 
model. Three levels (CBR worker, sub-district and indi- 
vidual) and two time points (6 and 12 months) will be 
included. Secondary and tertiary outcomes will be ana- 
lysed using mixed-effects linear regression models or 
logistic regression depending on the data   type. 
 
Cost-effectiveness  analysis 
Direct costs of the treatment will be estimated by deriv- 
ing a monetary value for each component of the treat- 
ment based on actual costs, and applying these to each 
individual based on the process indicators, which reflect 
the actual uptake of the treatment. Other  health  care 
costs and other patient- or family-borne costs will be 
computed and compared at 6 and 12 months, and sub- 
sequently related to changes in disability and clinical 
symptoms. Incremental cost-effectiveness ratios will be 
calculated to illustrate the extra cost incurred (if any) to 
produce a unit improvement in the main outcome of 
disability-adjusted life years (DALYs) calculated from the 
36-item WHODAS 2.0. In the event that dominance is   
not shown, i.e. the intervention is more effective but the 
costs are also more than the FBC group, incremental cost-
effectiveness ratios will be computed, together with their 
confidence intervals (using bootstrapping tech- niques to 
overcome expected skewness of cost data). Cost-
effectiveness acceptability curves will also be derived in 
order to show the probability of any cost-effective ad- 
vantages for the FBC plus CBR group at a range of ‘will- 
ingness to pay’ threshold levels. 
The results from the quantitative and qualitative work 
will be combined to give an overall assessment of the 
intervention effectiveness. 
 
Trial management and  monitoring 
The trial is sponsored by the London School of Hygiene 
and Tropical Medicine. A Data Safety and Monitoring 
Board (DSMB) has been convened to assure the con- 
tinuing safety of research participants. A clinical monitor 
will carry out onsite monitoring visits prior to the trial 
commencing, at recruitment, and at 6-month and 12- 
month follow-up. The trial coordinator will carry out day-
to-day monitoring and will also review recruitment rates, 
withdrawals and losses to follow-up. All protocol 




Trial-related assessments will take place in private loca- 
tions. A unique ID number will be linked to patient de- 
tails in hard and soft copy formats that are kept  in 
secure locations. Signed consent forms will be kept se- 
curely in a locked cupboard. All documentation that in- 
cludes patient data will be anonymised, but identifiable 
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through the ID number. Names of patients will not be 
quoted  or published. 
 
Discussion 
Human rights violations and the high disability burden     
of schizophrenia make the condition a priority area for 
public health action. The importance of rehabilitation 
services for schizophrenia in scaling up mental  health 
care is recognised by the WHO [18] and the Ethiopian 
government [32]. There is emerging evidence that CBR 
for schizophrenia is effective at improving disability out- 
comes in middle-income settings, yet there is no evi- 
dence on whether CBR can work in a setting with even 
fewer mental health resources, such as Ethiopia.  The 
RISE trial will determine the added value of CBR com- 
pared to FBC alone. This will help to determine, for 
scaling-up services, the importance of a dedicated re- 
habilitation service in addition to  FBC. 
 
Trial status 




provided specific input on the qualitative section. LA wrote the first and final 
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Ethical approval and consent to participate 
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study will be conducted in accordance with the recommendations for 
physicians involved in research on human subjects adopted by the 18th 
World Medical Assembly, Helsinki 1964 and later revisions. Any major 
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implemented until approval is received. All approved amendments will be 
reported to the sponsor, DSMB, trial registry and clinical monitor. 
 
 
Consent for publication 
Permission to conduct the trial in Sodo district was sought from the Sodo 
District Health Office before randomisation of the sub-districts. Information 
about the study will be given to patients and caregivers by a trained psychiatric 
nurse or trial nurse. A patient information sheet is available for participants to 
read. The majority of participants will be illiterate, and some patients will have 
cognitive difficulties, so information will be given orally using non-technical lan- 
guage. Sufficient time will be allowed for consideration of the information. Con- 
sent to enter the study will be independently sought from each patient and, 
   separately, from their caregivers. The trained nurse will assess the 
Additional file 1: SPIRIT checklist – RISE trial protocol. A checklist of the 
full protocol components according to the SPIRIT criteria. (PDF 106 kb) 
decision-making capacity of the patient. If the patient is deemed not to have 
capacity this will be documented and consent will be sought from the 
   caregiver and assent from the patient. Information about the study will still given 
to the patient, appropriate to their level of understanding. It is appropriate to 
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9.4.1 Policy	and	programmes	The	2012	Ethiopian	National	Mental	Health	Strategy	[59]	laid	out	plans	to	improve	the	availability	and	accessibility	of	mental	healthcare	and	highlighted	the	importance	of	rehabilitation	services	for	people	with	severe	mental	illness.	Yet	the	realisation	of	these	plans	remains	in	the	early	stages	and	there	is	little	detail	on	the	resources	or	services	that	will	be	provided	to	support	rehabilitation.	The	following	recommendations	are	formulated	on	the	basis	of	the	thesis	findings	to	address	the	current	gaps	in	care.	1. In	LMIC	such	as	Ethiopia,	a	community-based	intervention	such	as	CBR	should	be	provided	as	an	adjuvant	service	in	addition	to	facility-based	care	for	people	with	schizophrenia	who	experience	high	levels	of	disability.	The	community-based	service	should	include	home	visits	as	standard	and	should	involve	the	individual’s	family.	Community-based	care	should	be	linked	to	facility-based	care,	rather	than	existing	as	a	stand-alone	service.	2. Non-specialists,	such	as	CBR	workers,	who	are	recruited	from	the	local	area,	should	deliver	community-based	interventions.	Non-specialist	workers	represent	the	most	feasible	option.	3. The	fundamental	aims	of	the	community-based	service	should	be	to	support	livelihoods,	to	improve	understanding	of	schizophrenia,	to	maximise	family	stability	and	care	for	the	individual,	and	to	facilitate	engagement	with	
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	primary	care.	The	service	should	follow	recovery	principles	and	incorporate	a	shared	decision-making	approach.	4. A	facility-based	service	for	mental	health	should	be	provided	in	primary	care	in	line	with	the	WHO’s	mhGAP	guidelines.	The	workforce	providing	this	service	should	be	adequately	trained	and	supervised.			5. Robust	supply	and	financing	systems	should	be	set	up	to	ensure	there	is	continuous	provision	of	psychotropic	medication	to	primary	care.	Primary	care	treatment	options	should	be	expanded	to	include	depot	injections,	atypical	anti-psychotic	medications	(which	may	have	a	more	acceptable	side	effect	profile)	and	anti-cholinergic	medications	to	help	manage	extra-pyramidal	side	effects.	More	acceptable	medication	may	improve	the	acceptability	of	community-based	services	such	as	CBR,	as	well	as	improving	medication	adherence,	which	could	increase	the	impact.	Home-based	provision	of	medication	should	be	available	for	emergency	situations	and	the	most	remotely	located	households.		6. Anti-psychotic	medication	should	either	be	made	free	for	all	people	with	schizophrenia	or	available	through	a	workable,	transparent	and	accessible	national	health	insurance	scheme.		
9.4.2 Directions	for	future	research	1. A	briefer	or	less	intensive	version	of	the	CBR	intervention	could	be	developed	to	create	a	more	readily	scalable	model.	This	would	require	careful	analysis	of	the	trial	data	to	determine	which	components	of	CBR,	and	in	what	quantity,	are	essential	for	its	effectiveness.	For	example,	if	community	mobilisation	proves	to	have	minimal	contribution	to	the	impact	of	CBR	this	element	could	be	eliminated.	Conversely	if	most	of	the	effect	of	CBR	is	through	one	particular	pathway	(such	as	family	support,	livelihood	support	or	adherence	support),	these	components	could	be	prioritised	for	inclusion.	A	further	RCT	of	the	refined	intervention	would	then	be	needed.	2. More	research	is	needed	to	explore	the	applicability	of	the	recovery	model	in	LMIC	contexts.	The	exploratory	qualitative	work	underway	alongside	the	trial	should	provide	a	foundation	for	this.	Future	research	may	involve	the	
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